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Mono-(2-ethylhexyl) phthalate (MEHP) is the toxic metabolite of the common 
plasticizer di-(2-ethylhexyl) phthalate (DEHP). Exposure to DEHP or MEHP typically 
leads to testicular atrophy in laboratory animals. The prevalence of DEHP as an 
environmental contaminant is therefore cause for concern due to its potential to affect 
human testicular function and fertility. In the testis, MEHP induces the injury of the 
supportive cells called Sertoli cells, leading to Fas death receptor-dependent apoptotic 
elimination of germ cells. This dissertation examines the molecular mechanisms that lead 
to this loss of germ cells resulting from testicular exposure to MEHP. The p53 tumor 
suppressor protein is proposed as the cellular stress sensor that sensitizes specific germ 
cells to Fas-dependent cell death in response to the MEHP-induced Sertoli cell injury. 
This is based upon recent reports that demonstrate p53’s ability to initiate the localization 
  viii
of Fas to the plasma membrane of cells in a transcription-independent manner, in addition 
to its ability to transcribe various pro-apoptotic proteins including Fas. 
 
In experiments involving the exposure of pre-pubertal p53 wild-type and mutant 
mice (C57 x 129S/v) to a single oral dose of 1g MEHP /kg body weight, we were able to 
demonstrate that mice lacking the p53 gene were partially protected from the testicular 
toxicity induced by MEHP. These studies enabled us to establish that a lack of p53 
expression affected the activation of the Fas pathway in germ cells after MEHP exposure, 
partly by affecting Fas membrane localization and also by influencing the cellular 
retention of an inhibitor of this pathway, the c-FLIP (L) protein. To further clarify these 
results, we examined the effect of Fas activation in GC-2spd (ts) cells, which are germ 
cells that demonstrate variable activation of p53 depending on the temperature that they 
are maintained at. The activation of the p53 protein increased the sensitivity of GC-2 
cells to undergo Fas-mediated apoptosis by modulating Fas expression on the germ cell 
membrane.  Additionally, activation of Fas caused an increased tagging of c-FLIP (L) 
with ubiquitin, indicating its targeting for degradation. Thus the p53 status of GC-2 cells 
influenced the membrane expression of Fas, subsequently influencing the degradation of 
the anti-apoptotic protein c-FLIP (L). In summary, the results indicate that p53 promotes 
Fas activated germ cell apoptosis in response to MEHP-induced Sertoli cell injury, by 
instigating the degradation of c-FLIP (L) protein via its ubiquitinylation. 
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Chapter 1.  Introduction 
 
The plasticizer di-(2-ethylhexyl) phthalate (DEHP) is a common environmental 
contaminant that induces testicular atrophy in rodents and higher mammals (Kavlock et 
al. 2002). Of particular concern is the ability of DEHP to affect testicular functions in 
younger animals. Human fetuses, infants and children are at an elevated risk of exposure 
to DEHP from placental transfer, lactating milk, rattles, pacifiers, bottles, and toys.  
Therefore, in the last several decades, extensive studies have been conducted to 
determine the cellular and molecular determinants of DEHP toxicity in order to assess its 
effects on human reproductive health.  
 
DEHP toxicity mediated by its major toxic metabolite mono- (2-ethylhexyl) 
phthalate (MEHP) primarily targets the support cells of the testis or Sertoli cells (Gray 
and Gangolli 1986). The injured Sertoli cells are unable to perform various secretory and 
regulatory functions and also undergo specific ultra-structural changes (Creasy et al. 
1988). Hence, they cannot adequately execute their support role toward germ cells. 
Consequently, this leads to increases in germ cell death by a process called apoptosis and 
in case of longer exposures to DEHP or MEHP, to the appearance of testicular lesions 
and atrophy (Thomas et al. 1978; Richburg and Boekelheide 1996).  The work in our 
laboratory has been geared toward identifying the cellular stress sensors and activators 
that sensitize specific germ cell populations to die in response to the MEHP-induced 
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Sertoli cell injury. However, before a description of these studies is given, a description 
of the anatomy and physiology of the testis is provided in the following section.  
 
1.1. Overview of the Testis: 
 
 The paired mammalian testes reside in the scrotal sac below the main trunk of the 
organism (Russell 1990). Each testis in the scrotum is individually covered by an 
inelastic fibrous capsule called the tunica albuginea that imparts shape to the testis and 
maintains its contents. The testis is itself composed of two compartments: the 
seminiferous tubules and the interstitial compartment. The interstitial compartment is the 
less structurally organized of the two compartments and contains the blood and lymph 
vessels. The prominent cell types in the interstitial space are Leydig cells, which 
primarily secrete the hormone testosterone, and vascular cells including macrophages. 
The lymphatic space is not very well defined across species, but is commonly separated 
from the seminiferous tubules by endothelial cells. 
 
 The seminiferous tubules are coils of convoluted tubules. All the tubules begin 
and end at an excurrent duct system called the rété testis. Each tubule has multiple 
straight sections that follow the long axis of the testis and upon transverse cross-
sectioning of the testis appear almost circular or oval.  The seminiferous tubule wall is 
formed by one or more layers of myoid cells that separate the interstitium from the 
tubule’s contents. Myoid cells being of contractile nature are responsible for the tubule’s 
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movements to expel mature germ cells called spermatozoa. A basement membrane is 
found between the lymphatic endothelial cells and the myoid cells and also between the 
myoid cells and the cells of the tubule. The seminiferous tubule is composed of both 
Sertoli cells and germ cells in a distinctive spatial arrangement. The following sections 
will describe some of the physical and functional features of the interactions between 
Sertoli cells and germ cells. They will also emphasize how the unique relationship 
between the two cell types influences the balance between life and death for germ cells. 
 
1.1.1. The Sertoli cell and its Functions:   
 
The somatic cells of the seminiferous epithelium are the Sertoli cells. They were 
termed the ‘mother’ cells of the testis by Enrico Sertoli, who first described them in a 
paper published in 1865 (Sertoli 1865). Sertoli cells vary in size from 75-100 µm and 
appear columnar (Russell 1993; Skinner 2005). These cells are attached to the basement 
membrane and extend into the lumen of the seminiferous tubule. They have a number of 
cytoplasmic processes that go around and between various germ cells. They also possess 
a large polymorphic nucleus with distinct tripartite nucleoli (see Fig. 1.1 for 
representation of Sertoli cell-germ cell associations in the testis). The Sertoli cells 
function in a number of capacities within the testis. They perform roles that are as diverse 
as physical and nutritional support for germ cells, to active phagocytosis of germ cell 
cytoplasmic bodies and debris. Hence they influence the microenvironment within the 
tubules of the testis by affecting the structural, endocrine and nutritional components 
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essential for the survival and functioning of germ cells therein.  Sertoli cells perform their 
structural role by serving as physical scaffolds that maintain in place several germ cells at 
varying stages of division or differentiation. Sertoli cells also form a ‘blood testis barrier’ 
when they establish tight junctions with adjacent Sertoli cells. These tight junctions 
separate the seminiferous tubule into two compartments, a basal and an adluminal 
compartment. Tight junctions do not allow the movement of most macromolecules 
through them. The basal compartment abutting the basement membrane has access to 
resources from the vascular system, while the germ cells in the adluminal compartment 
are limited in the resources received due to the presence of the tight junctions. Hence 
these cells have to receive most substrates from Sertoli cell secretions. Sertoli cells 
therefore perform nutritive functions by delivering sugars, amino acids, energy substrates, 
lipids, metals, and vitamins; and secretory functions by secreting a variety of proteins, 
ions, hormones, proteases, metal carrier proteins, growth and paracrine factors to germ 
cells in the adluminal compartment and to other cells within the tubule as well.  
 
Regulatory factors secreted by Sertoli cells are typically glycoproteins. These 
include androgen binding protein that binds and transports testosterone; transferrin a 
ferric ion shuttling protein that moves these ions from the basal side of Sertoli cells to 
germ cells; other metal ion transport proteins; proteases that are involved in the tissue 
remodeling as specific germ cells called spermatids differentiate; several growth and 
paracrine factors such as insulin like growth factor I, transforming growth factors α and β, 
müllerian inhibiting substance, inhibin, activin and many more. These factors influence 
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Fig. 1.1. Schematic representation of Sertoli cell-germ cell interactions within 
seminiferous tubules. Sertoli cells extend from the basement membrane of the tubule to 
the lumen. Their cytoplasmic processes surround and support the various germ cell types. 
Stem germ cells divide to form spermatogonia (in basal compartment of tubule); 
spematogonia divide and differentiate to become spermatocytes, then round and elongate 
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the growth and proliferation of germ cells and also that of Sertoli cells. They also affect 
differentiation and other functions that affect the normal testicular function and fertility 
of the organism.   
 
1.1.2. Germ cells and Spermatogenesis: 
 
The process by which stem germ cells eventually form mature haploid cells called 
spermatozoa (the male gamete), is called spermatogenesis (Russell 1990). Sertoli cells 
play a very important role in maintaining this process of spermatogenesis. Sertoli cells 
ensure the transition of dividing and differentiating germ cells closer to the lumen of the 
tubule, so that germ cells may be released when they become spermatozoa. Additionally, 
the various regulatory proteins secreted by Sertoli cells as well as the hormones 
testosterone and FSH (follicle stimulating hormone), are critical for ensuring the growth, 
proliferation and differentiation of germ cells and hence the timing of spermatogenesis.  
 
Germ cells originate as stem germ cells that can be found in the basal 
compartment of the seminiferous tubule adjoining the basement membrane and Sertoli 
cell membranes (Russell 1990). These cells undergo mitotic cell division to either 
regenerate themselves or become the proliferative spermatogonia, Ap (p-paired).  Ap 
spermatogonia then undergo several mitotic divisions to generate Aal (al-aligned) cells 
with as many as 4-32 Aal cells found connected to each other via cytoplasmic bridges 
called intercellular bridges. These Aal cells undergo differentiation to become A1 
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spermatogonia. Successive mitotic cell divisions give rise to 5 more types of 
differentiated spermatogonia, A2-A4, In (intermediate) and B type cells. Thus, a thousand 
cells may arise from one stem cell spermatogonium.  Interestingly, the total numbers of 
Sertoli cells in the testis has been found to establish the upper limit of sperm cell 
production (Huckins 1978). Huckins (1978) demonstrated in his paper that only 25% of 
the theoretically possible numbers of pre-leptotene spermatocyte cells were produced 
from A1 spermatogonia. 
 
 Spematocytes are the germ cells that arise from the cell division of B type 
spermatogonia.  These are the preleptotene spermatocytes and they are the last germ cell 
type to undergo DNA synthesis. All the germ cells until the preleptotene stage are 
confined to the basal compartment of the seminiferous tubule. The preleptotene 
spermatocytes then transition to form leptotene spermatocytes and start to move away 
from the basal compartment. These cells move toward the adluminal compartment, 
passing through intermediate compartments that are formed by the breaking and 
reforming of tight junctions between two Sertoli cells. These primary spermatocytes then 
initiate meiotic cell division once they reach the adluminal compartment. Meiosis I which 
initiates the separation of homologous chromosomes is prolonged and prophase I 
(leptotene to pachytene to zygotene to diplotene phases) can take up to 3 weeks to 
complete. Secondary spermatocytes formed after meiosis I then undergo a shorter meiosis 
II and the genetic material is halved.  
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The haploid cells formed after meiotic cell divisions are called round spermatids. 
These cells then undergo the elaborate process of cell transformation without cell division 
called spermiation. The round spermatids progressively elongate, form flagella and refine 
their acrosomal structure while losing their extra cytoplasmic baggage. The formation of 
the motile flagellum and the acrosomal structure which carries lytic enzymes, along with 
the modification of cytosolic and nuclear material clearly signals preparations for 
fertilization. Elongate spermatids called spermatozoa are eventually released into the 
lumen of the seminiferous tubules. These spermatozoa pass through the rété testis and 
reach the epididymis.   
 
1.1.3.  Sertoli Cell Injury and its Importance to Germ Cell Viability: 
 
 Sertoli cell involvement in the maintenance of an appropriate extracellular 
environment for germ cells and in spermatogenesis, have emphasized the crucial role 
played by Sertoli cells in ensuring the well-being of germ cells within the testis. Studies 
on the effects of various chemical toxicants such as phthalates, 2,5-hexanedione, 
nitroaromatics like 1,3-dinitrobenzene, and the chemotherapeutic drug cisplatin in the 
testis (Strandgaard and Miller 1998; Lee et al. 1999; Sawhney et al. 2005) go a step 
further by demonstrating that causing Sertoli cell dysfunction eventually affects germ cell 
viability.  
 
In response to these chemical toxicants, several Sertoli cell functions were found 
to be affected. These included the alteration of the ultrastructure of Sertoli cells with the 
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modification of the microtubule filament and intermediate filament structures (Richburg 
and Boekelheide 1996; Boekelheide et al. 2003) and the formation of Sertoli cell 
vacuoles. The alterations in Sertoli cell structure may be responsible for observations of 
germ cell detachment in response to the Sertoli cell toxicants. These chemical exposures 
also caused disruption of Sertoli cells’ metabolic functions and disrupted 
hormone/regulatory protein secretions (Heindel and Chapin 1989; Williams and Foster 
1989; Thysen et al. 1990; Reeve et al. 2002). These were followed by observations of 
germ cell death by a process called apoptosis or programmed cell death leading to 
testicular atrophy. Thus the original definition of ‘mother cell’ for Sertoli cells was a very 
apt description of Sertoli cell functions. The loss of normal Sertoli cell functions appears 
to ultimately affect the ability of the testis to maintain their germ cell populations.  
 
The study of chemical toxicants affecting only Sertoli cells engenders an 
appreciation for the paracrine nature of these toxicity models. Germ cell death by the 
process of apoptosis turns out to be one of the primary consequences of Sertoli cell injury. 
When the ability to perform their normal support functions are compromised, Sertoli cells 
do not themselves undergo death in most cases, but cause the germ cells that are 
dependent on them for survival to die. Cell death by apoptosis is typically mediated in 
response to direct injury to the cells from a variety of cues including growth factor 
withdrawal, DNA damage, oxidative stress, loss of extracellular matrix support and 
others.  The Sertoli cell injury model offers us the unique opportunity to study the 
molecular and cellular changes associated with cell death due to indirect injury instead. In 
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our laboratory, we utilize the testicular exposure to phthalates to study germ cell 
apoptosis. However, before a description of this injury model can be provided, one must 
have a fundamental understanding of the process of apoptosis which is described in the 




 The word ‘apoptosis’ is derived from the Greek language and translates to mean 
‘falling of leaves’.  Apoptosis is a form of physiological cell death that was first observed 
in the development process of various multi-cellular organisms. This observation of cell 
death in different cellular systems was demonstrated several times over in the last 150 
years, but the term “programmed cell death” to describe cell death in tadpole and insect 
metamorphosis was first coined by Lockshin and Williams in 1965 (Lockshin and 
Williams 1965). In 1972, Kerr, Wyllie and Currie (Kerr et al. 1972) were the first to 
conceive of the now commonly used term ‘apoptosis’ to describe the process of 
controlled cell deletion. They believed that this term aptly described cell death based on 
the Greek meaning of the word. They were able to demonstrate that apoptosis was a basic 
biological phenomenon with distinct morphological features that could be initiated or 
inhibited by a variety of stimuli, both physiological and pathological and that it was 
initiated in all kinds of cells. 
 
Kerr et al. (Kerr et al. 1972) were the first to collectively describe all the 
morphological features associated with apoptosis; nuclear and cytoplasmic condensation, 
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membrane blebbing, the break up of the cells’ components into membrane bound 
fragments or apoptotic bodies, the uptake of the apoptotic bodies by other cells by 
phagocytosis, and degradation of the remnants of these cells. They very clearly 
demonstrated that apoptosis took place in a wide variety of tissues, adult, young or 
embryonic, neoplastic or normal tissue, in response to noxious agents, or as a 
physiological phenomenon in development or otherwise. They were also able to show the 
absence of inflammation after apoptosis.  
 
After this seminal paper, the field would get its next impetus from the genetic 
characterization of the nematode, Caenorhabditis elegans that was carried out by the 
groups of Horvitz and Sulston in the 1970’s. They made the discovery that 131 cells of 
the 1090 somatic cells of the worm always died during development. Horvitz’s group at 
the Massachusett’s Institute of Technology then went on to identify the key 
components/genes involved in the cell death program of the worm and their studies 
would provide some of the most basic insights into the initiation and propagation of the 
apoptotic machinery in cells. They identified the genes Ced-3and 4 as being essential for 
apoptosis and Ced-9 as being anti-apoptotic (Ellis and Horvitz 1986); (Hengartner et al. 
1992). Ced-3 and 4 are the worm homologs of the proteolytic enzymes called caspases 
and the adaptor protein APAF-1 (apoptotic protease activating factor-1), while Ced-9 is 
the homolog of Bcl-2, an anti-apoptotic protein family member. Meanwhile, in 1975 a 
serum factor induced by endotoxin in BCG (Bacillus Calmette-Guerin) vaccine infected 
mice was found to kill transplanted tumors (Carswell et al. 1975). The discovery of this 
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factor called the Tumor necrosis factor or TNF, would in turn lead to the discovery of 
other cytokines and death receptors that could initiate apoptosis in cells. 
 
Apoptosis is considered an important regulator of cellular homeostasis within 
tissues and organs. Apoptotic cell death does not merely sculpt organs during 
development, but also enables the removal of old and damaged components of the adult 
body in the absence of inflammation.  It therefore helps to maintain cell numbers and 
tissue size. Apoptosis can thus be deemed an essential and very fundamental 
physiological function for an organism and as necessary as cell proliferation and 
differentiation (Vaux and Korsmeyer 1999). The process of apoptosis also helps to 
defend the body by promoting cell death of the invading microorganism. However, if the 
process goes awry, it has been found to contribute to the pathogenesis of several diseases 
and disorders (Thompson 1995). Excessive cell death has been found to lead to 
autoimmune disorders such as AIDS (Acquired immunodeficiency syndrome), several 
neurodegenerative diseases such as Parkinson’s and Alzheimer’s, ischemic injury related 
myocardial infarction and stroke, amongst others. On the other hand, diseases associated 
with prolonged cell survival such as cancer, viral infections and immune disorders such 
as systemic lupus erythematosus arise in part due to a failure of apoptotic processes 
within the body. Apoptosis is also initiated when the cell is exposed to stress inducing 
conditions such as DNA damage, oxidative stress, growth factor withdrawal, radiation 
injury, chemical toxicants, and physical injury such as heat shock (Held 1997; Chandra et 
al. 2000; Rich et al. 2000; Robertson and Orrenius 2000; Beere 2001).  A cell will 
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typically try to repair the damage inflicted upon it and all attempts will be made to avert 
cell death. However, when the damage is irreparable, cells will turn on the cell death 
machinery. Understanding the nuances to this process will therefore remain one of the 
enduring questions for science.  
 
1.2.1. The Biochemistry of Apoptosis: 
  
The process of apoptosis is possible due to the concerted action of a family of 
cysteine proteases called caspases (for reviews see Hengartner 2000; Degterev et al. 
2003). A majority of the caspases are activated only after the initiation of apoptosis and 
are responsible for the basic cellular changes that eventually lead to cell death. These 
caspases are proteases with an active site cysteine moiety and they cleave all their protein 
substrates after an aspartate residue in the P1 position. Caspases typically recognize a 
tetrapeptide sequence with the aspartate residue being the C-terminal residue on all their 
substrates and usually cleave their substrates only at one or very few sites. Their action 
leads to protein activation or inactivation, or disassembly of a multiprotein complex, or 
the release of proteins from such a complex. Over 100 caspase substrates have been 
identified to date (Fischer et al. 2003).  
 
Some of the substrates cleaved by caspases are responsible for the characteristic 
morphological changes in cells undergoing apoptosis (Hengartner 2000; Fischer et al. 
2003). For instance, the cleavage of ICAD or inhibitory caspase activated DNase releases 
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the active DNase CAD which was in complex with ICAD. CAD is an endonuclease that 
cuts DNA at the linker regions between nucleosomes. This results in the formation of 
DNA fragments of lengths corresponding to multiples of 180 base pairs. These fragments 
of DNA can be visualized on an agarose gel as a ladder and is used typically as a marker 
of apoptosis in that cell population. Caspases also inactivate the DNA repair protein 
PARP (poly ADP-ribose polymerase) by cleavage and thus prevent repair of fragmented 
DNA. Caspases cleave a number of structural proteins such as lamins that lead to the 
collapse of nuclear lamina and hence the shrinkage and budding of the nucleus. They also 
cleave cytoskeletal proteins such as actin, tubulin, and vimentin, in addition to proteins 
involved in cell adhesion and anchorage such as FAK (focal adhesion kinase) and 
catenins.  The cleavage of PAK2 (p21 activated kinase) and the structural proteins fodrin 
and gelsolin, are believed to contribute to the formation of membrane blebs. 
 
Other caspase substrates are several signaling molecules which when activated are 
involved in the signaling reactions necessary to advance the apoptotic state. Caspases 
themselves are activated by cleavage by other caspases. Proteins such as Bid, MEKK1 
(MAP kinase kinase kinase 1), some forms of PKC (protein kinase C), calcineurin, etc. 
which are involved in stress signaling are activated by caspase cleavage. On the other 
hand, proteins involved in DNA repair and survival signaling, such as ATM (ataxia 
telangiectasia mutated protein), DNA-PK (DNA-dependent protein kinase), Akt, HSF 
(heat shock factor) are typically inactivated. Thus caspases are the basic work-horses of 
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the apoptotic machinery that are responsible for most of the reactions leading up to cell 
death. 
 
Apoptotic cells are cleared from the extracellular milieu by phagocytes or by the 
phagocytic action of neighboring cells. However, for apoptotic cells to be recognized for 
clearance, a signaling system has evolved which involves the amino phospholipid, 
phosphotidyl serine (PS) (Savill and Fadok 2000; Schlegel and Williamson 2001). PS is 
typically present in the inner leaflet of the plasma membrane lipid bilayer. In apoptotic 
cells, the PS is externalized and serves as a signal for macrophages and other phagocytic 
cells. The asymmetric distribution of phospholipids in the plasma membrane is disrupted 
during apoptosis by the inactivation of an ATPase or translocase that keeps PS 
internalized and also by the activation of a scramblase protein that externalizes PS. The 
signals that activate this event are not well defined, but seem to be largely caspase-
independent. Macrophages in turn express lectin-like receptors, integrin receptors, 
scavenger receptors, and other molecules which may or may not act in concert to 
recognize PS. Once apoptotic bodies are cleared from the field and their components 
recycled, the process is essentially completed. 
 
1.2.2. Activation of Caspases, the Effectors of Apoptosis: 
 
 There are 11 known human caspases, 11 murine caspases, 7 Drosophila caspases 
and 4 in C. elegans (for review see Degterev et al. 2003). Caspases possess an active site 
cysteine- which is part of a conserved pentapeptide ‘QACXG’ sequence. Caspase-1 or 
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interleukin 1-β processing enzyme (ICE) was the first human caspase discovered. Like all 
proteases, caspases are expressed as zymogens or inactive forms of themselves. The most 
important question that then arises is, how do these ‘effectors’ of apoptosis get activated? 
 
 Caspase zymogens are composed of three domains- an N-terminal prodomain, a 
p20 and a p10 domain (Degterev et al. 2003; Hengartner 2000). These zymogens are 
processed by cleavage to separate the p20 and p10 domains first and then the p20 domain 
from the prodomain. The active enzyme is a heterotetramer consisting of two p20 and 
two p10 subunits with two active sites at the opposite ends. Interestingly, the processed 
sites on caspases are also the tetrapeptide motifs with aspartate at the P1 position 
common to all caspase substrates, indicating that caspases proteolytically process 
themselves. Indeed, the group of caspases called executioner caspases comprising the 
short prodomain caspases, 3, 6 and 7, are cleaved by active initiator caspases. The 
activated executioner caspases then become involved in most of the reactions previously 
described that initiate the biochemical and morphological changes during apoptosis. This 
process of caspase activation however does not account for the activation of the very first 
caspases in this cascade, namely the initiator caspases.   
 
Initiator caspases include caspases 1, 2, 4, 5, 8-12, and 14 and have longer 
prodomains than the executioner caspases.  Caspases 4, 5, 10 and 14 are strictly human 
caspases, while caspases 11 and 12 can only be found in mice. Caspase 1, 5 and 11 are 
involved in mediating inflammation, while the remaining initiator caspases are involved 
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in mediating apoptosis. The two initiator caspases that are most commonly activated in 
response to various stress stimuli are the caspases 8 and 9. Caspase-8 is the key initiator 
caspase in death receptor activated apoptotic pathways, while caspase-9 is the primary 
caspase that initiates cell death via the mitochondrial stress pathway. In response to 
apoptosis inducing stimuli, these caspases are typically recruited to multi-protein 
complexes, where their increased concentration and proximity to other zymogen 
molecules is thought to enable autocatalytic processing of the caspases. In fact, a model 
called the ‘induced proximity model’ was proposed in 1999 by Salvesen and Dixit 
(Salvesen and Dixit 1999) that predicted that the clustering of initiator caspases would 
allow for their self-processing and activation, as the zymogens possessed some latent 
proteolytic activity themselves. Interestingly, caspase-9 possessed high catalytic activity 
when in the presence of its cytosolic co-factors and did not seem to require cleavage to be 
activated (Stennicke et al. 1999). Recent studies by Salvesen’s group (Boatright et al. 
2003) have led to the proposal of a unified model for apical caspase activation. They 
were able to demonstrate that both caspases 8 and 9 were activated by dimerization and 
that internal proteolysis of these caspases was a secondary event after dimerization of the 
caspases.  The model for apical caspase activation may still undergo further refinement, 
but that for executioner caspases remains straightforward. Executioner caspases are 
incapable of processing substrates unless they are themselves activated, and this adds a 




1.2.3. The Adaptors in the Apoptotic Pathway: 
  
 To enable death signals to be transmitted to the caspases, multiprotein complexes 
are formed in the cell. In case of caspase-8, death receptors activated at the cell 
membrane by their ligands bind to an adaptor protein called FADD (Fas associated death 
domain protein) via interactions between death domains (DD) at their C-terminal ends 
(Chinnaiyan et al. 1995; Boldin et al. 1996). FADD, in turn through its N-terminal death 
effector domain (DED), binds to one of the two DED’s expressed on the prodomain of a 
caspase-8 zymogen molecule (Muzio et al. 1996; Medema et al. 1997). The complex 
formed by activated death receptors, FADD and caspase-8 is called the death-inducing 
signaling complex or DISC. Caspase-8 monomers brought in proximity to each other at 
the DISC are then activated by autocatalytic processing. 
 
 Signaling through the mitochondrial pathway involves the release of an inner 
membrane mitochondrial protein called cytochrome c. Caspase 9 is activated when it is 
bound to its adaptor protein APAF-1, the mammalian homologue of Ced-4, via 
interactions between their caspase recruitment domains (CARD) (Hofmann et al. 1997). 
CARD domain may be found as part of the prodomain of caspase-9. The two proteins 
along with cytochrome c and ATP/dATP form a very large protein complex called the 
apoptosome (~700-1400 kDa), which enables caspase-9 to achieve the right conformation 
for activation (Cain et al. 2002). 
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 Thus the processing and activation of the initiator caspases 8 and 9 is achieved by 
the formation of large complexes, the DISC and the apoptosome respectively. The 
formation of these complexes is achieved by protein-protein interactions via conserved 
domains, namely DD’s, DED’s and CARD’s which are composed of 6 α-helices and are 
conserved across species (Hofmann et al. 1997). 
  
1.2.4. Regulators of Apoptosis: 
 
 Regulators of apoptosis are those proteins that either directly bind to adaptors that 
recruit initiator caspases and affect caspase activation, or bind directly to caspases 
themselves, or alter the function of key pro-/anti-apoptotic proteins, and therefore alter 
cell fate. Thus these proteins can either be inhibitors or pro-apoptotic proteins themselves.  
 
 c-FLIP (cellular-FLICE inhibiting protein) is an inhibitor of the death receptor 
activated pathway that binds the adaptor protein FADD, when FADD is present in the 
DISC (Irmler et al. 1997). The c-FLIP protein was discovered at about the same period of 
time by 7 independent groups (Goltsev et al. 1997; Han et al. 1997; Hu et al. 1997; 
Inohara et al. 1997; Irmler et al. 1997; Shu et al. 1997; Srinivasula et al. 1997). The 
protein has been shown to exist as three alternately spliced forms, (L), (S) and (R) (Irmler 
et al. 1997; Golks et al. 2005). All three forms have considerable homology to the 
caspase-8 molecule. The (L) form structurally resembles the caspase-8 protein the most, 
with two N-terminal DED’s and a caspase catalytic domain without the active site 
  20
cysteine. The (S) and (R) forms of c-FLIP contain only the prodomain with its two 
DED’s, followed by a short stretch of amino acids.  c-FLIP (S) and (R) completely inhibit 
caspase-8 cleavage, while the (L) form will allow partial processing of caspase-8 at the 
DISC (Krueger et al. 2001; Golks et al. 2005). The role of c-FLIP (L) in caspase-8 
inhibition remains controversial as it has been alternatively described as pro- or anti-
apoptotic by different groups; however it appears that the level of expression of the c-
FLIP (L) predisposes its ability to act as a pro- or anti-apoptotic protein (higher the 
expression, more anti-apoptotic its effect) (Chang D.W 2002; Micheau et al. 2002; 
Boatright et al. 2004). In addition, their results (Chang D.W 2002; Micheau et al. 2002; 
Boatright et al. 2004) indicate that c-FLIP (L) forms a heterodimer with the caspase-8 
molecule more readily than caspase-8 homodimer formation at the DISC. The formation 
of the heterodimer does not prevent activation of the caspase-8 zymogen, but perhaps 
restricts the heterodimer to the DISC. Thus, the caspase-8 homodimer may mediate 
cytotoxicity by its ability to move to the cytosol, while the caspase-8-c-FLIP (L) 
heterodimer acts locally at the cell membrane and is restricted in its choice of substrates. 
 
 Another key regulator at the DISC is the receptor interacting kinase or RIP. RIP is 
a serine threonine kinase that can induce apoptosis when overexpressed (Nagata 1997). It 
has been shown to bind the Fas death receptor via DD’s (Peter and Krammer 2003) but 
preferably binds the adaptor protein TRADD at the DISC of activated TNF death 
receptors. RIP bound to TRADD recruits other proteins that mediate the activation of the 
pro-survival NFκB (NF- nuclear factor) pathway (Nagata 1997). The adaptor protein 
  21
TNF receptor associated protein 2 (TRAF2) is also recruited to the DISC, where it is 
implicated in activating the stress kinase c-Jun N-terminal kinase (JNK).  
 
 The Bcl-2 family of proteins are amongst the most important regulators of 
apoptosis expressed by cells. This family has both pro- and anti- apoptotic members and 
about 20 mammalian members are known to exist (for review see Cory et al. 2003). The 
Bcl-2 proteins respond to intracellular stress cues such as DNA damage and cytokine 
deprivation and the interaction between opposing family members ultimately decides the 
fate of the cell. The pro-survival members of the family include Bcl-2, Bcl-xL, and Bcl-w, 
while the pro-apoptotic proteins include Bax, Bak, Bid, Bim, Noxa, Puma, etc. This 
family of proteins can also be subdivided based on the presence of certain domains in 
their protein structure. The anti-apoptotic proteins and the Bax sub-family of pro-
apoptotic proteins (Bax, Bak and Bok) carry three conserved BH domains, BH1, 2 and 3 
while the BH3 only sub-family of pro-apoptotic proteins expresses only the BH3 domain. 
The BH3 only proteins when activated typically block the activity of the anti-apoptotic 
Bcl-2 proteins by docking in the hydrophobic groove formed by their BH1, 2 and 3 
domains. Bid is the only BH3 only protein that interacts directly (albeit transiently) with 
the Bax proteins. Bax and Bak form oligomeric pores on the mitochondrial membranes in 
response to apoptotic cues and enable the release of cytochrome c. Thus the Bcl-2 
proteins play a very important role in initiating the mitochondrial stress pathway, leading 
to the activation of caspase-9 and other downstream effectors of apoptosis. Bcl-2, 
originally discovered as an oncogene in human follicular lymphoma, is also a very 
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critical survival molecule that is responsible for providing another source of checks to the 
apoptotic process.  
 
 The inhibitors of apoptosis or IAP family of proteins directly bind to both initiator 
(caspase-9) and executioner caspases (caspase-3 and -7) and block their activity (for 
review see Liston et al. 2003). This family of proteins which include c-IAP 1 and 2, 
XIAP and Survivin are cytosolic proteins with 70-80 amino acid domains called 
baculoviral IAP repeat (BIR) domains with which they bind to caspases. IAP’s with 
multiple BIR domains bind caspase-9 through their BIR3 domain and caspases 3 and 7 
through their BIR2 domains. These proteins also carry a Ring zinc finger domain (RZF) 
at their C-terminus that possesses E3 ubiquitin ligase activity. These RZF’s enable the 
IAP’s to target the caspases bound to them for degradation. Negative regulators of IAP’s 
are also expressed by cells. These include the mitochondrial proteins Smac/Diablo and 
Omi/HtrA2. Smac and Omi are released from the mitochondrial inter-membrane space 
when apoptotic signals cause cytochrome c release. Both proteins once released usually 
bind IAP’s at their BIR domains and prevent their activity, thereby enabling apoptotic 
pathways to proceed.  
 
1.2.5. Apoptotic Pathways: 
 
Initiation of apoptotic signaling pathways in a cell occurs typically by the 
activation of death receptors on the cell membrane, or when the mitochondria release 
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mediators of apoptosis in response to stress stimuli. These two pathways are not the only 
transduction pathways, but are certainly the two main ones that eventually lead to 
activation of executioner caspases and the reactions mediated by them. Schematic 
representations of these two pathways are presented in Figs. 1.2 and 1.3.  
 
 Death receptors are members of the TNF receptor family/nerve growth factor 
(NGF) receptor family (for reviews, see Nagata 1997; Ashkenazi and Dixit 1999). The 
members of the family that mediate cell death include the TNF receptors 1 and 2, DR3 
(DR- death receptor, Apo-3), Fas (Apo-1, CD95), DR4 (TRAIL-R1), DR5 (TRAIL-R2, 
Killer), DR6, DcR1 and 2 (DcR-decoy receptor) and osteoprotegrin (OPG). The receptors 
contain 2-6 repeats of a cysteine rich subdomain in their extracellular domain, a 
transmembrane domain and a cytosolic domain that carries the death domain. Decoy 
receptors and OPG are incapable of transmitting death signals due to the lack of 
extracellular or cytosolic domains or the presence of truncated domains. The other death 
receptors transmit signals via their DD interactions as mentioned in section 1.2.3.  These 
receptors are only activated when they are bound to their cognate ligands as trimers.  
 
Interestingly, both TNF receptors and Fas pre-associate as trimers via pre-ligand 
binding association domains (PLAD) before they are activated and do not trimerize only 
when bound to their ligands as originally predicted (Chan et al. 2000; Siegel et al. 2000). 
The death ligands are members of the TNF subfamily of cytokines and are TNF, FasL, 




Fig. 1.2. Representation of the apoptosis pathway initiated by the activation of death 































































































cytoplasmic N-terminus and an extracellular C-terminal tail and are type II membrane 
proteins. The binding of the death ligands to death receptors put into motion a signal 
transduction cascade which involves the formation of the DISC, activation of proximal 
caspase-8 enzymes and the downstream proteolysis and activation of executioner 
caspases. 
 
 The second apoptotic pathway which involves the mitochondria proceeds due to 
the initiation of mitochondrial outer membrane permeabilization (MOMP) (for review see 
Green and Kroemer 2004). MOMP is accompanied by the dissipation of the 
mitochondrial inner transmembrane potential or ∆ΨM. This causes the release of proteins 
found in the space between the inner and outer mitochondrial membranes such as 
cytochrome c, AIF (apoptosis inducing factor), Smac, etc. MOMP is usually caused by 
the formation of a pore in the inner and outer membranes together, called the 
permeability transition pore or PT pore, or by the formation of a pore only on the outer 
membrane created by the oligomerization of Bax and/or Bak. The PT pore is formed by 
the adenine nucleotide transporter (ANT) and the voltage dependent anion channel 
(VDAC). Some reports indicate that Bax and Bak can bind to the VDAC as well. MOMP 
is triggered by a variety of stimuli, including viral proteins, increased intracellular Ca2+, 
reactive oxygen species, metabolic perturbations, toxicants like ethanol, heavy metals and 
salicylates, etc. MOMP also eventually leads to loss of mitochondrial functions which are 
critical for the cell to survive. Cytochrome c once released binds to APAF-1 in the 
presence of ATP/dATP and together they can bind caspase-9 to form the apoptosome. 
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Fig. 1.3. Representation of the apoptosis pathway initiated by mitochondrial stress. 
The formation of the apoptosome by caspase-9, APAF-1, dATP and cytochrome c 
released from the mitochondria, leads to the activation of executioner caspases and hence 
apoptosis. 
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 The activation of caspase-9 in turn leads to activation of caspases 3, 6 and 7. Executioner 
caspases eventually cleave subunits in the respiratory complexes I and II of the 
mitochondria, thereby completely destroying mitochondrial energy production and hence 
putting the cell well on its way to cell death.  
 
 The two apoptotic pathways described can also be categorized as type I and II 
pathways (Scaffidi et al. 1998). Cells that are described as type I cells typically activate 
caspase-3 due to robust formation of the DISC complex after FasL exposure, leading to 
the activation of large amounts of caspase-8 which cleave procaspase-3. Type II cells 
alternatively do not mediate the formation of such a strong DISC complex when exposed 
to FasL.  Instead, minimal caspase-8 activation leading to the cleavage of the Bid protein, 
the binding of t-Bid to Bax and/or Bak and the subsequent MOMP occurs, and caspase-3 
is activated due to the activation of caspase-9. Thus type I cells such as thymocytes and 
peripheral T cells may initiate cytochrome c release in response to FasL, but will still 
undergo cell death in spite of Bcl-2 over-expression (Scaffidi et al. 1998; Huang et al. 
1999). Hepatocytes on the other hand, which are type II cells, fail to undergo apoptosis in 
the presence of excess Bcl-2.   
 
1.3. The Phthalate Injury Model and Germ Cell Apoptosis 
 
 In our laboratory we study the effects of different environmental and therapeutic 
chemicals including phthalates and cisplatin on testicular function. This section will 
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provide a brief introduction to di-(2-ethylhexyl) phthalate or DEHP, which is a 
commonly used plasticizer in polyvinyl chloride (PVC) products and other plastics. A 
discussion of the general characteristics of DEHP, its toxicity profile and how this relates 
to testicular changes will also be provided.  
 
DEHP imparts flexibility to plastics and is utilized widely in a number of 
commercial products (this information is based on the National Toxicology Program-
Center for Evaluation of Risks to Human Reproduction or the NTP-CERHR panel report 
on DEHP, published in October 2000; available online at 
http://cerhr.niehs.nih.gov/news/phthalates/DEHP-final.pdf or as published in the journal 
Reproductive Toxicology in 2002, Kavlock et al. 2002). It is used in the manufacture of 
building products (wallpaper, cable and wire insulation), car products (car seats, vinyl 
upholstery), clothing (footwear, raincoats), food packaging, children’s products (toys), 
and in medical devices (IV bags, blood storage bags, etc.). Due to its lack of covalent 
bonding to the PVC, DEHP leaches out from these various objects. Hence DEHP gets 
widely dispersed in the environment from its release during manufacture, from consumer 
goods, and during their waste incineration. DEHP bio-accumulates but does not bio-
magnify in the food chain, as it can be metabolized and is biodegradable. The typical 
routes of exposure to DEHP are via ingestion and inhalation. The physical properties of 
very low vapor pressure and poor water solubility limit DEHP’s concentration in the air 
and water to 10-3 to 101 ppb (parts per billion). Thus, the chief route of exposure to DEHP 
is though ingestion.  The range of human exposure from all sources excluding non-
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dietary ingestion and medical and occupational exposure are an estimated 3-30 µg/ kg of 
body weight/ day.  
 
 Anxiety about the use of phthalates and especially DEHP in consumer products 
has arisen from the observation of liver, kidney, testicular and developmental toxicity in 
various organisms (for reviews see Thomas et al. 1978; Kavlock et al. 2002). In fact, the 
observation of testicular atrophy and anti-androgenic effects in very young rodents has 
led to the ban of DEHP’s use in children’s products such as pacifiers, rattles and teethers 
in the US and Canada. DEHP when orally ingested by different organisms cause the 
following liver effects: peroxisomal proliferation, increased liver weights, hepatocellular 
hypertrophy and hyperplasia sometimes leading to formation of adenomas and 
carcinomas (in rodents), and increases in enzyme markers relevant to peroxisomal 
proliferation. However, DEHP is not classified by the US regulatory agencies as a 
carcinogen as the studies that produced the carcinomas in rodents used extremely high 
daily doses of DEHP, beyond normal exposure levels. Developmental toxicity in rodent 
pups exposed in-utero to DEHP typically manifested itself as morphological 
abnormalities of the axial and appendicular skeleton, cardiovascular system, and the eye 
and neural tube, while kidney effects of DEHP included decreased kidney weights in 
males and increased weights in females.  
 
The NOAEL or ‘no observed adverse effect level” for DEHP toxicity from DEHP 
exposure studies in rodents have been highly variable on account of the duration, species 
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and age differences in each study. One study on the general toxicity of DEHP reported a 
NOAEL as low as 3 mg/kg body weight/day. Based on these results and considering that 
the typical daily exposure to DEHP does not exceed 3-30 µg/ kg of body weight/ day for 
human adults, the ambient exposure to DEHP cannot be considered toxic. Therefore, one 
needs to justify studying reproductive toxicity as caused by DEHP and its main 
metabolite mono-(2-ethylhexyl) phthalate.  
 
1.3.1. Mono-(2-ethylhexyl) Phthalate and Sertoli Cell Injury: 
 
 DEHP is a testicular toxicant and causes changes such as decreased testicular 
weights, testicular lesions and atrophy, and changes in androgen hormone secretion when 
different organisms are exposed to the toxicant (Kavlock et al. 2002). However, it is a 
product of DEHP metabolism, called mono-(2-ethylhexyl) phthalate or MEHP that 
produces the effects attributed to DEHP for testicular toxicity in rodents (Gray and 
Gangolli 1986; Sjoberg et al. 1986). MEHP is a monoester phthalate produced by the 
hydrolysis of DEHP by stomach, pancreatic and intestinal esterases (for review see Albro 
and Lavenhar 1989) (Also see Fig. 1.4 for representation of the hydrolysis reaction 
involved in the metabolism of DEHP to MEHP). Sensitivity to the testicular effects of 
DEHP is species specific with rodents being the most sensitive, and dogs, marmosets and 
monkeys being less sensitive. This variation in sensitivity may be attributed to the 
differences in the metabolism of DEHP. Humans can typically cause phase II 




Fig 1.4. Schematic representation of the hydrolysis reaction involved in the 
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and subsequently excrete it, while rats and mice further hydrolyze MEHP (Schmid and 
Schlatter 1985). Interestingly, human children up to 3 months of age do not possess the 
ability to glucuronidate and they may also receive DEHP and MEHP via milk from their 
mothers or through placental transfer (Dostal et al. 1987; Cresteil 1998).  
 
With exposure to phthalates from toys, placental transfer, lactating milk, pacifiers, 
bottles and other objects, human fetuses, infants and younger children are exposed to 
DEHP at much higher levels than adults. Recent studies also revealed that when rats were 
exposed to DEHP in utero during their period of sexual differentiation (from gestational 
day 14 to post natal day 3), this led to reduced testosterone synthesis (Gray et al. 2000; 
Parks et al. 2000). This in turn caused the demasculinization of the male pups as they 
displayed decreased anogenital distances, retention of nipples, a vaginal pounch, cleft 
phallus with hypospadias, undescended testes in some cases, and other changed features 
that were retained into adulthood. In addition, the testicular effects of DEHP and MEHP 
are age-dependent, with fetal, neonatal and young pre-pubertal rats being the most 
sensitive to their effects and the adult animals being insensitive (Gray and Gangolli 1986; 
Dostal et al. 1987; Teirlynck et al. 1988; Li et al. 2000).  Thus, with slightly deficient 
xenobiotic-metabolism capabilities and at the appropriate age for toxicant effects to be 
more intense, concern has been raised about the effects of phthalates on the future 




The other interesting aspect to MEHP toxicity is its cell specificity. MEHP 
specifically targets Sertoli cells of the testis. Research by several labs demonstrate that 
Sertoli cells are the primary targets as evidenced by reduced androgen binding protein 
and seminiferous tubule secretions only in immature rats (Gray and Gangolli 1986); germ 
cell detachment from Sertoli cell-germ cell co-cultures only after MEHP exposure and 
not with DEHP (Gray and Gangolli 1986);  reduced proliferation of Sertoli cells in 
neonatal rats (Dostal et al. 1988; Li et al. 2000); alterations in Sertoli cell vimentin 
filaments and cell ultrastructure (Creasy et al. 1988; Richburg and Boekelheide 1996); 
reduced pyruvate secretion, transferrin secretion, cellular ATP levels and mitochondrial 
succinate dehydrogenase activity in cultured Sertoli cells (from pre-pubertal rats) exposed 
to MEHP; increased lactate production (Chapin et al. 1988; Moss et al. 1988; Thysen et 
al. 1990); and inhibition of FSH stimulated cyclic AMP accumulation in Sertoli cell 
cultures also from immature rats (Heindel and Chapin 1989).  
 
In addition, in their 1986 study, Gray and Gangolli (Gray and Gangolli 1986) 
demonstrated that MEHP did not cross the blood testis barrier in young rats and hence 
was not directly in contact with germ cells of the adluminal compartment. Further studies 
demonstrated that spermatocytes and spermatids were the primary germ cell types that 
underwent apoptosis in response to MEHP in pre-pubertal rodents (Dostal et al. 1988; 
Richburg and Boekelheide 1996; Giammona et al. 2002). Hence, the phthalate injury 
model is ideal to study the mechanisms governing indirect injury to germ cells as 
previously discussed in section 1.1.3. The use of pre-pubertal (or immature) animals in 
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our study ensures a paracrine model of toxicity, without the inherent death of the injured 
cells themselves to confuse the issue. In our laboratory, we study the molecular and 
cellular changes that lead to germ cell apoptosis after exposure of rodents to MEHP.  
These studies will ultimately help us in understanding how fertility may be maintained or 
how testicular injury may be alleviated in males despite exposures to various 
environmental insults.  
 
1.3.2. Physiological vs Pathological Control of Germ Cell Apoptosis: Participation of the 
Fas-FasL Signaling Pathway in Germ Cell Apoptosis in Response to Cellular Stress: 
  
    Testicular germ cell apoptosis has been observed under both physiological and 
pathological conditions. As mentioned in section 1.1.2, the number of Sertoli cells in a 
seminiferous tubule limits the numbers of germ cells they can support (Huckins 1978). 
Thus, germ cell proliferation is balanced in the testis by their cell death and this process 
is critical for the continued fertility of the organism. Indeed, dysregulation of the 
physiological germ cell apoptotic processes can lead to either the formation of testicular 
cancers or conversely to the decreased fertility of the organism. 
 
 To control the clonal expansion of germ cells, the apoptosis of type A2, A3 and A4 
spermatogonia is routinely observed in the testis (Allan et al. 1987). Various cues 
including paracrine signals (stem cell factor (SCF), leukemia inhibitory factor, desert 
hedgehog) and endocrine signals (testosterone and pituitary gonadotrophins) regulate 
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germ cell numbers in the normal testis (for review see Print and Loveland 2000). The loss 
of signals from the survival factor SCF, or androgen withdrawal or the use of a 
gonadotrophin antagonist leads to increased germ cell apoptosis (Billig et al. 1995; 
Woolveridge et al. 1999; Guerif et al. 2002). In addition, for the development of 
functional spermatogenesis, the first wave of spermatogenesis is accompanied by a 
massive wave of germ cell apoptosis which occurs during the 3rd week of life in rodents 
(Rodriguez et al. 1997). Interestingly, both the pro- and anti-apoptotic members of the 
Bcl-2 family are required for this process to occur normally. Bax-deficient mice and Bcl-
2 transgenic mice have both been found to skip this first wave of apoptosis, followed by a 
complete break-down of spermatogenesis and end up being sterile (Knudson et al. 1995; 
Rodriguez et al. 1997; Russell et al. 2002).  Another member of the Bcl-2 family, the 
Bcl-w protein, is also critical for the efficient functioning of spermatogenesis. Bcl-w is 
found expressed in Sertoli cells and in other cell types within seminiferous tubules, 
except in spermatids. The lack of Bcl-w expression leads to the progressive loss of both 
germ cells and Sertoli cells in these mice (Russell et al. 2001).  
 
Other cellular regulators such as the tumor suppressor protein p53 have also been 
examined for their role in germ cell apoptosis. In mice expressing reduced amounts of 
p53, a testicular giant cell degenerative syndrome has been observed (Rotter et al. 1993). 
p53 which is a protein that regulates the processes of apoptosis, cell cycle arrest and 
DNA repair (details discussed in the next section) is normally detectable only in 
pachytene spermatocytes (Schwartz et al. 1993). Thus the reduced expression of p53 in 
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these meiotic cells may account for the formation of giant cells that are genetically 
defective. However, the appearance of giant cells is mouse strain specific and depending 
on the background strain, p53 null mice can be fertile (Rotter et al. 1993). Interestingly, 
the death receptor Fas and its ligand FasL may not be involved in physiological germ cell 
death. One report (Boekelheide et al. 1998) suggested that Fas and FasL expression was 
increased in rats between the ages of 16-35 days. However, male mice lacking the 
functional FasL protein (gld mice) and/ or p53 did not seem to have any overt 
reproductive or developmental defects, while their female counterparts had 
developmental abnormalities and were sub-fertile (Embree-Ku and Boekelheide 2002). 
Therefore, based on studies of the various knockout and transgenic mice, it would appear 
that physiological germ cell apoptosis in the testis is primarily mediated by the Bcl-2 
family members and that this may be influenced by either paracrine or endocrine factors.  
 
 In contrast, depending on the type of physical injury or chemical toxicant to 
which rodents have been exposed, the Fas-FasL system plays a partial or primary role in 
the initiation of germ cell apoptosis. Thus, the death receptor-ligand system may 
predominantly function in a situation where stress-induced germ cell death occurs instead 
of being involved in apoptosis initiated under normal conditions in the testis. 
Interestingly, the Fas receptor is predominantly expressed in germ cells, while FasL is 
expressed in Sertoli cells (Lee et al. 1997; Richburg et al. 1999; Koji et al. 2001). The 
expression of FasL in Sertoli cells may explain the immune privilege of the testis 
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(Bellgrau et al. 1995).  The cellular localization of these two proteins is therefore 
important for the paracrine activation of cell death in germ cells.  
 
The following examples will help in the appreciation of the role played by Fas 
during testicular injury. When testicular torsion of spermatic cords which impedes blood 
flow to the testis and causes ischemic conditions is alleviated by reperfusion of the 
tubules, this leads to an increase in germ cell apoptosis (Lysiak et al. 2000; Koji et al. 
2001). The release of cytochrome c and the increased expression of Fas in the 
spermatocytes and spermatids undergoing cell death in response to this injury, implicate 
both the mitochondrial and the death receptor pathways in germ cell apoptosis caused by 
ischemia-reperfusion. Testicular exposure to radiation on the other hand, indicates a role 
for p53 and Fas in spermatogonial apoptosis (Beumer et al. 1998; Lee et al. 1999; 
Embree-Ku et al. 2002). Spematogonia of p53 null mice are radio-resistant as are germ 
cells expressed by mice carrying a dysfunctional Fas gene, or the lprcg mice. In yet 
another physical injury model to the testis, that of cryptorchidism involving the retraction 
of the testis into main trunk of the organism and thereby the elevation of its ambient 
temperature, both p53 and Fas may have a role to play in germ cell death. Using p53 null 
mice and lpr mice (also dysfunctional for Fas receptor), researchers demonstrated a 
sequential mechanism of p53- and Fas-mediated germ cell apoptosis in cryptorchid testes 
(Ogi et al. 1998; Yin et al. 2002). However, not all responses to testicular injury utilize 
the Fas-FasL pathway. Exposure to mild testicular hyperthermia involves the activation 
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of Bax-mediated germ cell apoptosis without activation of the death receptor pathway 
(Yamamoto et al. 2000; Vera et al. 2004). 
 
When rodents are exposed to chemical toxicants such as 2,5 hexanedione and 
MEHP, Fas and FasL proteins prove to be the critical regulators of germ cell apoptosis 
(Lee et al. 1997; Lee et al. 1999). In fact, when gld mice (lacking functional FasL) were 
exposed to MEHP, they were significantly protected against its toxicity (Richburg et al. 
2000; Giammona et al. 2002). The specific injury to Sertoli cells by both 2,5 hexanedione 
and MEHP is a very critical aspect to these injury models. Both toxicants caused an 
increase in FasL expression in Sertoli cells and the concomitant increase in Fas on germ 
cell membranes, followed by enhanced germ cell apoptosis (Lee et al. 1997; Lee et al. 
1999; Richburg et al. 1999). Based on the above research, it was postulated that injury by 
these toxicants to the main ‘support’ cell of the testis abrogated the ability of these Sertoli 
cells to maintain normal functions and led to the paracrine elimination of Fas expressing 
germ cells.  
 
As discussed in section 1.1.3, the injury to Sertoli cells provides us with a unique 
opportunity to study germ cell apoptosis initiated by indirect injury. Thus, the observation 
of Fas-mediated germ cell apoptosis in response to phthalate induced injury to Sertoli 
cells forms the basis for the commencement of this thesis. An interesting question that 
arose from these observations was the question of how Fas was ‘regulated’ or ‘directed’ 
or ‘activated’ in germ cells after MEHP exposure.  MEHP does not directly injure germ 
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cells and no biochemical changes in germ cells except for the Fas response and the 
subsequent apoptosis of germ cells had been reported. It was therefore intriguing to 
determine how germ cells sensed stress from the injured Sertoli cells and how this 
elicited a Fas mediated apoptotic response. To answer these questions, we proposed a 
role for the p53 protein in the germ cell apoptosis caused by testicular exposure to MEHP 
and the reasons are explained in the subsequent section.  
 
1.4. p53 and its Potential Role in MEHP Mediated Germ Cell Apoptosis: 
 
DNA double strand breaks and lesions, chromosomal aberrations, activation of 
oncogenes, hypoxia, ribonucleoside triphosphate depletion, cold and hot shock, excess 
nitric oxide and growth factor withdrawal are examples of conditions of cellular stress 
that can cause the activation of a very unique molecule called p53 (for reviews see  
Levine 1997; Harris and Levine 2005). Over 50% of human cancers have been reported 
to contain mutations in the p53 gene. In fact, a report in 1994 by Hollstein M et al. 
(Hollstein et al. 1994) compiled over 2500 somatic mutations of the p53 gene in various 
human tumors and tumor cell lines. This list albeit long, was actually incomplete and did 
not include germ-line mutations that can cause individuals to inherit faulty alleles of the 
p53 gene, like those suffering from the Li-Fraumeni syndrome. p53 is thus the most 
critical tumor suppressor protein in the cell and this is borne out by the sheer number of 
functions that have been attributed to this protein. In response to different kinds of 
cellular stress, p53 can mediate cell cycle arrest, senescence, DNA repair, differentiation 
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or apoptosis. It is able to carry out such diverse functions because of its ability to 
transactivate a large number of genes in a sequence specific manner (for reviews see 
Stewart and Pietenpol 2001; Vousden and Lu 2002). Thus, genes encoding proteins 
involved in a variety of functions such as p21, 14-3-3-σ and GADD45 that are involved 
in cell cycle arrest, Fas, DR5, PUMA, Noxa and Bax in apoptosis, and the xeroderma 
pigmentosum p48 protein in DNA repair are all target genes transactivated by p53.  
 
The human p53 protein is 393 amino acids long and can be divided into three 
functional domains, an acidic amino-terminal transactivation domain, a central DNA 
binding domain and a basic carboxy-terminal oligomerization domain (for reviews see 
Levine 1997; Stewart and Pietenpol 2001). p53’s ability to function as a transcription 
factor is based on the binding of co-factors to, and modifications of the N-terminal 
transactivation domain. For example, Mdm-2 which is the chief regulator of p53’s 
functions, keeps the p53 protein inactive in normal cells by binding to it at the N-
terminus and targeting it to the proteosome for degradation. The phosphorylation of 
various serine and threonine residues in the transactivation domain by stress-response 
kinases in the cell affects the interaction between Mdm-2 and p53, allowing the release of 
p53 from Mdm-2. This allows p53 to localize to the nucleus where it binds to the 
promoter regions of various genes via its DNA binding domain. The DNA binding 
domain recognizes four repeats of a specific consensus sequence, namely 5’ 
PuPuPuC(A/T) 3’, arranged as pairs of inverted repeats. The transactivation domain 
meanwhile completes its functions by interacting with various co-factors and proteins of 
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the transcription machinery to enable the initiation of transcription.  The C-terminal 
domain on the other hand, contains both the nuclear localization signal and the nuclear 
export signal, along with an oligomerization domain. The oligomerization domain plays a 
part in the transcriptional process as well. It enables the homo-tetramerization of p53, 
which is required to initiate transcription. The nuclear export signal gets masked in the 
process and p53 is retained in the nucleus to complete its work. In addition, the C-
terminus is also phosphorylated and acetylated and these modifications are also important 
for the activation of p53. Hence, depending on the source of cellular stress, p53 is 
modified in a number of different ways by phosphorylation, acetylation, methylation, 
sumoylation and ubiquitination to mediate the appropriate response of inhibition of 
cellular progression to enable repairs, or apoptosis or senescence to terminate the life 
cycle of a cell (for review see Woods and Vousden 2001).  
 
1.4.1. The Role of p53 in Apoptosis: 
 
The first response to cellular stress by p53, does not always lead to the initiation 
of apoptosis. Unless the cellular damage is severe and hence irreparable, cells prefer not 
to initiate the cell death machinery which is quite irrevocable. In fact, DNA repair was 
found to be initiated in the early stages of p53-induced apoptosis in the mouse mammary 
carcinoma cell line MOD and the apoptotic response was reversed if the apoptotic 
stimulus was removed (Geske et al. 2000). In addition, most of the apoptotic proteins that 
are transactivated by p53 (exception being PUMA) have lower affinity binding sites for 
  42
p53 at their promoter sites, than do proteins such as p21 and Mdm-2 (Vousden and Lu 
2002). Therefore, it is suggested that p53 may activate several apoptotic mediators 
simultaneously depending on the nature of the cellular stress and the cell type exposed to 
it. For example, in human leukemia cells, Bax and Fas were only up-regulated in cells 
containing functional p53 (Kobayashi et al. 1998) or in the BV173 cells, but not in p53 
null HL60 cells. However, depending on the source of stress, exposure to radiation or 
treatment with the chemotherapeutic drug ara-C, the specific regulators involved in 
initiating apoptosis were different.  Fas was activated by p53 in the BV173 leukemic cells 
only after exposure to ara-C and not after radiation exposure, while Bax was up-regulated 
by both treatments.  
 
p53 mediated apoptosis can proceed through the death receptor activated pathway 
or through activation of the mitochondrial pathway. In a variety of cell types, the 
expression of Fas and/or DR5 can be induced to initiate apoptosis in a p53-dependent 
manner when cells are exposed to either ionizing radiation or chemotherapeutic drugs 
(Wu et al. 1997; Kobayashi et al. 1998; Muller et al. 1998; Wu et al. 1999; Petak et al. 
2000; Burns et al. 2001). DR5 null mice were radioresistant in an organ specific way 
(Finnberg et al. 2005) while lpr mice (having a functional mutation of the Fas protein) 
displayed thymocyte apoptosis in response to the radiation exposure (Strasser et al. 1995).  
Additionally, p53 also triggered the apoptosis of thymocytes and spleenocytes in vitro, in 
response to radiation damage in a Fas-independent manner (Fuchs et al. 1997). The other 
dysfunctional Fas mutant mice, lprcg mice, were found to have significantly reduced germ 
  43
cell apoptosis after exposure to ionizing radiation (Embree-Ku et al. 2002). Thus, as 
mentioned in the previous paragraph, p53 can activate mediators of apoptosis based on 
the context of the cells’ surroundings and the source of stress.  
 
Alternatively, p53 mediates the release of cytochrome c leading to the induction 
of apoptosis via the mitochondrial pathway. This release of cytochrome c is based upon 
the movement of Bax to the mitochondrial membrane (Schuler et al. 2000; Gao et al. 
2001). Additionally, mice or cells deficient for Apaf-1, Bid, caspase-9, Noxa or PUMA 
were all found to protect cells (from different organelles/sources) from p53-induced 
apoptotic responses (Soengas et al. 1999; Sax et al. 2002; Villunger et al. 2003). 
 
A transcription-independent role for p53 during apoptosis has also been 
demonstrated. In 1998, Bennett M et al. (Bennett et al. 1998) showed that in human 
vascular smooth muscle cells, activation of p53 caused the trafficking of Fas receptors 
from the storage vesicles of the Golgi to the cell membrane in a transcription-independent 
manner. This sensitized the cells to apoptotic cell death. p53 also directly acts at the 
mitochondria to release cytochrome c and initiate apoptosis in response to DNA damage 
or hypoxia, amongst other things (Marchenko et al. 2000; Sansome et al. 2001; Chipuk et 
al. 2004; Erster et al. 2004). In these studies, a fraction of cytosolic p53 localized to the 
mitochondrial membrane or inter-membrane space. p53 was described to act in a similar 
fashion to the BH3 only proteins like Bid, and caused the oligomerization of Bax at the 
mitochondrial membrane while releasing all pro-apoptotic Bcl-2 proteins from their 
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interaction with Bcl-xL. Thus p53 may augment its transcriptional activation of apoptotic 
proteins with the non-transcriptional activation of either death receptors or the 
mitochondrial stress pathway.  
 
1.4.2. The role of p53 in MEHP-mediated germ cell apoptosis : Hypothesis and Specific 
Aims: 
 
Given the extremely important role played by p53 in cellular apoptosis, it would 
be reasonable to assume that p53 may be involved in mediating germ cell apoptosis in 
response to MEHP toxicity, as a ‘universal stress sensor’. Moreover, germ cell apoptosis 
is an extremely important physiological process that ensures the correct transmission of 
information to progeny. Therefore, the involvement of a critical tumor suppressor protein 
in mediating this process after toxicant induced injury is likely. As mentioned in section 
1.3.2, response to MEHP toxicity to Sertoli cells manifests itself as Fas-mediated germ 
cell apoptosis. Fas is a p53-transcribed gene and appears to also be modulated in a 
transcription-independent manner by p53. Additionally, spermatocytes which always 
express detectable levels of p53 (Schwartz et al. 1993)are the predominant germ cell type 
to undergo apoptosis after testicular exposure to MEHP in pre-pubertal rodents (Richburg 
and Boekelheide 1996). This raises the possibility that these cells may regulate Fas 
expression in response to MEHP in a p53-dependent manner.  
 
Exposure to MEHP may not cause direct injury to the germ cells, but leads to the 
loss of germ cell attachment to Sertoli cells and decreased nutritional support to germ 
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cells by the injured Sertoli cells. p53 is typically described to transactivate death 
receptors in response to DNA damage or other specific cellular injuries. However, in the 
absence of overt cellular damage, we postulate that p53 mediates changes in germ cell 
Fas expression by a transcription-independent mechanism in response to MEHP mediated 
stress. In pre-pubertal rats exposed to MEHP, previous work by this laboratory has 
demonstrated that an increased localization of Fas receptors on germ cell membranes is 
critical for ensuring germ cell apoptosis (Richburg et al. 1999). These observations 
therefore lead up to the working hypothesis of this dissertation: “p53 sensitizes germ cells 
to Fas mediated apoptosis by modifying the membrane localization of Fas, after exposure 
to MEHP”.  
 
 In order to determine if p53 plays a role in germ cell apoptosis in response to 
testicular toxicity caused by MEHP, our first specific aim involved testing the response of 
pre-pubertal mice lacking p53 protein expression (p53 -/-) and their wild type littermates 
(p53+/+) to an acute oral dose of MEHP. These mice were also utilized to characterize 
the differences in Fas response to MEHP, i.e. its localization to germ cell membranes, 
based on the p53 status of the mice. Analyses of DR5 receptor membrane localization 
was also carried out in testicular cells, as a means to compare the effect of p53 activation 
on one of its alternate transcriptional targets. To further clarify the functional significance 
of our in vivo results, in our second aim, we analyzed the relationships between these 
proteins in a transformed germ cell line called GC-2spd (ts) cells. The activation of p53 
in these cells could be modified by altering the temperature at which they were grown as 
  46
the cells express a temperature sensitive mutation of the p53 protein. This enabled us to 
model the cells as p53+/+and p53 -/- cell types as well. The results from our experiments 
are presented in subsequent chapters. 
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 Approximately three week old, male C57BL/6J x 129S/v chimeric mice were 
obtained from The University of Texas M.D. Anderson Cancer Center, Science Park 
Research Division, Smithville, TX. These mice were either deficient for p53 (p53-/-) or 
were wild- type littermates (p53+/+) and were originally created at UT MDACC, 
Houston by Dr. Lawrence Donehower’s research group (Donehower et al. 1992). All 
animals were acclimatized for 1 week prior to experiments. The animal room climate was 
kept at a constant temperature (74 + 2°F) at 35-70% humidity with a 12h alternating 
light-dark cycle. Animals were given standard lab chow and water ad libitum. All 
procedures involving animals were performed in accordance with the guidelines of the 
University of Texas at Austin’s Institutional Animal Care and Use Committee in 
compliance with guidelines established by the National Institutes of Health.  
 
2.2. Cell Culture and Treatment Protocols 
 
Germ cell-2 spermatid (temperature sensitive) cells or GC-2spd (ts) cells were 
obtained from the American Type Culture Collection (Rockville, MD). They were 
cultured at 37 ºC in a 5% CO2 atmosphere, in Dulbecco’s modified Eagles’s media 
(DMEM, Life Technologies, Carlsbad, CA) containing 4.5g/L glucose, L-glutamine, 110 
mg/L sodium pyruvate, pyridoxine hydrochloride, and supplemented with 10% fetal 
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bovine serum, and 100 units/ml penicillin-streptomycin. These cells express a 
temperature sensitive p53 mutant protein (p53Val-135), which completely localizes in the 
nucleus only at the lower temperature of 32 ºC, and not at 37 ºC (Hofmann et al. 1994). 
In all experiments, p53 was activated by transferring cells cultured for 24 h at 37 ºC, to an 
incubator maintained at 32 ºC for a further 24 h.  
 
GC-2 cells that had been in culture for 48 h (grown at either temperature) were 
exposed to various treatments including JO2 (anti mouse-Fas antibody, 554254, 
Pharmingen, San Diego, CA, at 5µg/ml), Hamster IgG (Isotype control for JO2, 553961, 
Pharmingen, at 5µg/ml), mono-(2-ethylhexyl) phthalate (MEHP, TCI America, Portland, 
OR, at 200 µM), DMSO (Sigma Aldrich, San Diego, CA, at equivalent volume as 
MEHP), MG132 (Alexis Biochemicals, 260-092-M001, San Diego, CA, at 0.5, 1, 5 and 
10 µM) and human TRAIL (TRAIL was a kind gift from Dr. Shawn B. Bratton; used at 
1µg/ml) for time periods indicated in the results. For experiments involving pretreatment 
of GC-2 cells with the cholesterol depletor, methyl β-cyclodextrin (MBCD, C4555, 
Sigma Aldrich, at 1, 5 and 10 mM), cells were exposed to MBCD in serum free media for 
30 min at 37 ºC. The cells were then washed to remove any trace of MBCD and then 
exposed to JO2. Only cells maintained at the p53 permissive temperature were subjected 
to MBCD pretreatment and were returned to 32 ºC for the JO2 treatments thereafter, for 
the indicated periods of time shown in the results.  The concentrations used for JO2 and 
MEHP treatments were based on previous studies in primary cell cultures from testicular 
cells (Lee et al. 1997; Lee et al. 1999).   
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2.3. MEHP Exposure Protocol 
 
 To evaluate the consequences of MEHP-induced Sertoli cell injury on testicular 
germ cell apoptosis, 26-30 day old male mice (p53+/+ and p53-/-) were given a single 
dose of MEHP (1 g/kg) by oral gavage, a standard procedure for the investigation of 
MEHP-induced testicular toxicity (Thomas and Thomas 1984).  Both the dose and the 
time points used were selected based on our previous work (Lee et al. 1997; Lee et al. 
1999; Richburg et al. 1999; Giammona et al. 2002). MEHP (>97% purity) was purchased 
from TCI America. Animals received MEHP in corn oil at a volume equal to 4 ml/kg. 
Control animals received a similar volume of vehicle (corn oil). Vehicle and MEHP-
treated animals were killed by CO2 inhalation at the time points indicated. Both testes 
were rapidly removed, one testis was quickly frozen in liquid N2 and stored at -80°C and 
the other testis was immersion fixed overnight in Bouin’s solution (Polysciences, Inc., 
Warrington, PA), washed in 70% EtOH-Li2CO3 (saturated solution, Mallinkrodt, Paris, 
KY) and embedded in paraffin.  
 
2.4. Analysis of Apoptotic Index in Testicular Cross-Sections by TUNEL Assay 
 
Apoptotic fragmentation of DNA in mouse testis cross sections was evaluated using 
terminal deoxy-nucleotidyl transferase-mediated digoxigenin-dUTP nick end labeling 
(TUNEL) using the ApopTagTM kit (Intergen, Purchase, NY) and standard protocols for 
paraffin sections as previously reported (Seaman et al. 2003). 4 µm paraffin sections 
from Bouin’s fixed and paraffin embedded testes were obtained. Following warming at 
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60 ºC for 1 h, the sections were placed in Citru SolvTM (Fisher Scientific, Pittsburgh, PA), 
rehydrated in a graded alcohol series and boiled in 0.01 M sodium citrate solution to 
unmask antigens. The sections were then soaked in 2% H2O2 solution to quench 
endogenous peroxidase activity. Digoxigenin-dUTP end-labeled DNA was detected with 
anti-digoxigenin-peroxidase antibody followed by peroxidase detection with 0.05% 
diaminobenzidine (DAB; Peroxidase substrate kit, Vector Labs, Burlinggame, CA) as the 
substrate. After antibody and substrate development, the tissue sections were 
counterstained with a 1:14 dilution of hematoxylin in water. TUNEL-positive germ cells 
were quantified in each tissue section by counting the number of brown TUNEL-positive 
cells in each round seminiferous tubule. The apoptotic index reflects the percentage of 
seminiferous tubule cross sections with >3 TUNEL-positive germ cells. Two testis cross-
sections per mouse, with a minimum of at least 100 tubule cross-sections, were analyzed 
and the data are presented as averages ± SEM from 3-4 mice. In the control mouse testis, 
the percentage of seminiferous tubules with more than three TUNEL-positive cells is 
approximately 4%, so an increase in apoptosis is easily determined using this method of 
analysis.  
 
2.5. Apoptosis Measurement in GC-2 Cells by Flow Cytometry   
 
The Annexin V-Propidium Iodide (PI) assay was used to identify apoptotic cells 
via Annexin-V’s ability to bind to externalized phosphotidylserine molecules (van 
Engeland et al. 1998). PI is expelled from live and early-apoptotic cells which maintain 
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their cell membrane integrity, while being retained by dead cells or cells undergoing 
secondary necrosis/late apoptosis.  These cells are then identified based on their 
“apoptotic” characteristics (Annexin positive-stain or Annexin and PI positive-stain) 
using a flow cytometer. Cells in culture after appropriate treatment(s) were collected by 
trypsinization at 400g for 6 min.  They were re-suspended in fresh media for about 30 
min to neutralize the effects of trypsin. The cells were pelleted by centrifugation at 400g 
and the cell pellets were suspended in 1X binding buffer (from the ApoAlert Annexin-V 
FITC apoptosis kit, Clonetech, San Diego, CA) to wash them. They were collected once 
again by centrifugation and the cell pellet was re-suspended in 1X binding buffer. 
Approximately 105-106 cells/ sample were incubated with 5 µl of Annexin-V conjugated 
with fluorescein isothiocyanate (FITC) available from the kit, for 5-10 min. The cells 
were then incubated with 10 µl of PI for 2-5 min. Flow cytometric analysis of these cells 
was then carried out on a Coulter Epics XL cytometer. 
 
2.6. Immunocytochemistry (ICC) 
 
Localization of Fas or p53 was examined in acetone-methanol (1:1)-fixed, Triton 
X-100 permeabilized, GC2 cells grown on chamber slides (Lab Tek, 154526, Hatfield, 
PA) with or without a 3 h JO2 treatment, using rabbit (anti-Fas, sc-716) or goat (anti-p53, 
sc-1312) polyclonal antibodies purchased from Santa Cruz Biotechnology, Santa Cruz, 
CA. The primary antibodies were detected using Alexa-fluor® 488 conjugated secondary 
antibodies from Molecular Probes, Eugene, OR. Images were viewed using a Nikon E800 
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microscope, captured with the Nikon Cool-SNAP digital camera, and processed using 
MetaMorph Imaging System software (v 6). Assay controls included incubation of the 
cells without primary antibody or by substituting the primary antibody with rabbit/goat 
IgG at the same dilution as primary antibody.    
 
2.7. Immunoprecipitation (IP)  
 
GC-2 cells were treated with JO2 for a period of 3 or 6 h before being collected 
for analysis. Cells were lysed using a RIPA lysis buffer containing 150 mM NaCl, 1% 
IPEGAL, 0.5 % sodium deoxycholate, 0.1% SDS, 50 mM Tris (pH 8.0), and 1 mM 
PMSF. Lysates were pre-cleared with 50 µl (50 % slurry) of protein-G sepharose beads 
(Amersham Pharmacia Biosciences, Piscataway, NJ) in 500 µl of the lysis buffer for 1 h. 
The supernatant was retained following clearing, and was incubated with 2.5 µg of a rat 
monoclonal anti-c-FLIP antibody (ab16078, AbCam, Cambridge, MA) for an hour at 4 
ºC. Following this incubation, 50 µl of sepharose was added to the supernatant and the 
incubation continued for a further two hours. The captured antibody-protein-G complexes 
were then washed thrice with lysis buffer and once with PBS. After the addition of SDS 
running buffer, protein G was removed from the protein complex by boiling for 5 
minutes, after which the complexes were loaded onto a 10-12% Bis-Tris gel and 
separated by electrophoresis. The proteins were transferred to a nitrocellulose membrane 
and subsequently detected with the c-FLIP rat monoclonal antibody or a rabbit polyclonal 
antibody against ubiquitin (SPA-200, Stressgen, Victoria, BC).    
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2.8. Semi-Quantitative RT-PCR Analysis and Real Time-PCR Analysis 
 
Total RNA was isolated from testicular tissue or GC-2 cells using the QIAGEN 
(Valencia, CA) RNeasy RNA isolation kit. First strand complementary cDNA was made 
using 1 µg (for GC-2 cells) or 2 µg (for testicular tissue) total RNA in the presence of 
Superscript II reverse transcriptase and oligo-dT primer (both from Life Technologies, 
Carlsbad, CA). PCR reaction was performed using 2 µl of the cDNA product and Taq 
DNA polymerase (Roche Applied Science, Indianapolis, IN). PCR products of 469bp for 
Fas, 297bp for c-FLIP (L) and 389bp for β-actin were amplified using the following 
primers for Fas, 5’ catgccaacctggtaaaaaaaaagttgagg 3’ and 5’ 
attggtatggtttcacgactggaggttcta 3’; c-FLIP (L), 5’ aatgtggactctaagcccctgcaacc 3’and 5’ 
cgtaggagccaggatgagtttcttcc 3’; and β-actin, 5’ aggcatcctgaccctgaagtac 3’ and 5’ 
tcttcatgaggtagtctgtacg 3’. β-actin mRNA was used as an internal control for the semi-
quantitative analysis. Conditions for the co-amplification of Fas and β-actin were 92ºC 
for 1 min, 59ºC for 1 min, and 72ºC for 35 sec for 38 cycles in 1.5 mM MgCl2, while that 
for the co-amplification of c-FLIP (L) and β-actin were 92ºC for 1 min, 58ºC for 1 min, 
and 72ºC for 40 sec for 32 cycles in 1.5 mM MgCl2. 
The primers for the real time-PCR reaction for c-FLIP (L) were 5’ 
aaccccagaccgttggtgt 3’ and 5’ cgccaagctctgctcca 3’; and for β-actin were 5’ 
ccagcagatgtggatcagca 3’ and 5’ cttgcggtgcacgatgg 3’. Primers were designed with the aid 
of Primer Express, generating a 64 bp product for both β-actin and c-FLIP. Real time was 
performed on a Stratagene Mx3000P thermocycler using the Brilliant SYBR green PCR 
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master mix (600548, Stratagene, La Jolla, CA). The PCR conditions included a 10 min, 
95 °C activating cycle, followed by 45 amplification cycles of 95 °C for 30 sec, 60 °C for 
1 min, and 72° C for 30 sec. To control against mRNA variation between samples, actin 
controls were used for each sample. A baseline calibrator was run for each cDNA set 
used and individual samples were run in duplicate. As the expression levels of each 
sample were normalized to a single calibrator sample, the results from the samples at 
both temperatures can also be compared with each other.  
 
2.9. siRNA Transfection Protocol 
 
Small interfering RNA or siRNA technology is used to cause sequence specific 
degradation of mRNA (of a desired gene), thereby resulting in gene silencing. We 
obtained siRNA against mouse c-FLIP (S/L) (sc-35389) from Santa Cruz Biotechnology. 
It was utilized to knock down the protein expression levels of c-FLIP (L) in GC-2 cells. 
GC-2 cells were plated in 6 well culture plates in DMEM media containing serum, but 
lacking antibiotics. The cells were allowed to grow to 40-50% confluence before being 
transfected with siRNA against c-FLIP or with a control siRNA that was fluorescein 
tagged. The siRNA was incubated in transfection medium along with the transfection 
reagent (both provided by Santa Cruz for use in siRNA transfection protocols) at room 
temperature for 25 min before being added to culture wells. The appropriate quantities of 
each reagent used, was based on the recommendations of the company. The cells were 
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incubated with the siRNA mixture for a period of 24-48 hours and then subjected to 
mRNA or protein analysis, as discussed in the results. 
 
2.10. Sucrose Density Gradient Ultra-centrifugation for the Isolation of Lipid Raft 
Domains within Cell Membranes 
 
The protocol for sucrose density gradient ultracentrifugation was adapted from the 
protocol by Gajate and Mollinedo (Gajate and Mollinedo 2001), with modifications. 
Frozen mouse testes or GC2 cells were homogenized in 1 ml of lysis buffer containing 10 
mM Tris-HCl (pH 7.5), 5 mM EDTA, 150 mM NaCl, 1 mM sodium orthovanadate, 1 
mM PMSF and 1 % Triton X-100. The nuclear and other cellular debris were removed by 
centrifugation at 1000g for 10 min. The supernatant was then mixed with an equal 
volume of an 80 % sucrose solution (made in the lysis buffer without PMSF and Triton 
X-100) and added to the bottom of an ultra-centrifuge tube. The mixture was further 
over-layed with 4 ml of a 30 % sucrose solution, followed by 4 ml of a 5 % sucrose 
solution (both sucrose solutions also made in lysis buffer lacking PMSF and Triton X-
100). The entire sucrose density gradient column was then subjected to 
ultracentrifugation using a swinging bucket rotor in an Optima XL-100 centrifuge at 
140,000g for 16 h at 4 ºC. Fractions were collected from the top of the ultra-centrifuge 
tube, with the top most fraction being designated fraction 1 and the bottom-most, being 
fraction 10. Lipid raft domains should be the fractions with the lowest buoyant density 
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and are detergent resistant. Thus the top fractions in the column, collected in the 5-30 % 
sucrose gradient region are likely to be the lipid raft domains or fractions.  
 
2.11. Western Blot Analysis  
 
Frozen mouse testes/GC2 cell pellets (collected by trysinization and 
centrifugation at 400g for 6 min) were placed in homogenization buffer (either in 
phosphate buffered saline containing 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 
100 µM sodium orthovanadate, 10 µM E64, and 1X Complete Mini protease cocktail 
(Roche Applied Science, Indianapolis, IN) for total lysate preparation, or in buffer 
containing 20 mM Tris-HCl (pH 7.4), 2 mM EDTA, 25 mM NaF, 1 mM sodium 
orthovanadate, 1 mM dithio threitol, 1 µg/ml Aprotinin, and 1 µg/ml leupeptin for 
samples undergoing membrane fractionation) and homogenized with a Dounce 
homogenizer. For total lysate preparation, homogenized samples were incubated on ice 
for 30 min, centrifuged at 14,000g for 20 min at 4 ºC, and supernatants collected. 
Homogenized samples for membrane fractionation were immediately centrifuged at 
100,000g for 1h at 4 ºC. The pellet was lysed in fractionation buffer containing 0.8% 
Triton X-100. After 20 min of incubation, the pellet suspension was centrifuged at 
12,000g for 15 min and the supernatant collected. The concentration of proteins in the 
samples was determined using the Bio-Rad DC protein assay (Bio-Rad Laboratories, 
Hercules, CA).  
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Equal concentrations of proteins from samples were applied to NuPage 10% Bis-
Tris gels (Invitrogen, Carlsbad, CA) and electrophoresed. Seperated proteins were 
transferred onto a PVDF membrane (Invitrogen) and incubated with primary antibodies 
against caspase-8 (AAP-118, Stressgen, Victoria, BC, Columbia), c-FLIP (06-697, 
Upstate Cell Signaling Systems, Charlottesville, VA), DR5 (AF837, R&D Systems Inc., 
Minneapolis, MN), or Fas (sc-716, SantaCruz Biotechnology).  Horseradish peroxidase-
conjugated secondary antibodies (SantaCruz Biotechnology) were used to detect primary 
antibodies. Signals were detected by the use of an ECL kit (Amersham Pharmacia 
Biosciences). Images were collected by a Kodak DC-290 digital camera and 
densitometric analysis carried out using Kodak 1D Image Analysis Software (Kodak 
Digital Sciences, Rochester, NY). Each protein was analyzed in a minimum of 3-4 
independent groups of mice or GC-2 sample sets, and representative blots have been 
presented. Equal loading was verified by either comparing expression levels of actin or, 
when analyzing testicular or GC-2 plasma membrane protein levels, by staining the blots 
with amido-black. 
 
Western blot analyses of Fas and Flotillin-2 expression were performed for 
fractions separated by sucrose density gradient ultracentrifugation (procedure discussed 
in section 2.10) from testicular or GC-2 samples. Equal volumes of each fraction for each 
sample were loaded onto a 10 % Bis-Tris gel and electrophoresed. All the fractions from 
each sample were analyzed together. Additionally, for testicular samples from each 
MEHP treatment set, only fraction 5 for each sample was also analyzed on a blot together. 
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The procedure for western transfer, protein detection with primary and secondary 
antibodies, signal detection with ECL and image collection and analysis with the 
KODAK 1D software were carried out as described in the previous paragraph. The 
primary antibody for Flotillin-2 was obtained from BD Transduction Labs (610383, San 
Jose, CA).  
 
2.12. Statistics  
 
Significance between groups was evaluated using parametric single factor 
analysis of variance (ANOVA) with Fisher’s protected least significance differences 
(PLSD) test comparison with a significance value of p<0.1 using StatviewTM software 
(SAS Institute Inc., Cary, NC). The significance value of p<0.1 was considered based on 
the high degree of variability in the results from in vivo experiments. The range in ages of 
the animals used in these experiments from 26-30 days of age, could perhaps account for 
the variation. 
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Chapter 3:  The p53 protein influences the sensitivity of testicular germ cells 
to MEHP-induced apoptosis by increasing the membrane levels of Fas and 
DR5 and decreasing the intracellular amount of c-FLIP 
 
3.1. Introduction and Rationale 
 
In the rodent testis, the participation of the Fas signaling system has been 
observed in response to different forms of testicular injury including chemical injury, 
cryptorchidism, radiation injury, and ischemia-reperfusion (Lee et al. 1997; Ogi et al. 
1998; Lee et al. 1999; Koji et al. 2001; Embree-Ku et al. 2002). Our group has 
previously reported that Sertoli cells express FasL and initiate the apoptotic elimination 
of Fas-expressing germ cells in a paracrine manner, after challenge with MEHP (Lee et al. 
1997; Lee et al. 1999). In contrast, other investigators have reported that FasL is only 
expressed by mature spermatozoa and play a role in their survival in the female genital 
tract (D'Alessio et al. 2001). As discussed previously in section 1.3.2 of Chapter 1, 
evidence for a functional role of FasL/Fas signaling within the testis after injury comes 
from studies utilizing gld mice. Although gld mice display apparently normal 
spermatogenesis, after exposure to MEHP these mice exhibit a significant reduction in 
the incidence of germ cell apoptosis as compared to their wild-type (C57BL/6J) 
counterparts (Richburg et al. 2000; Giammona et al. 2002). Therefore, the significant 
attenuation of testicular germ cell apoptosis in gld mice indicates the functional 
participation of the Fas-signaling system in MEHP-induced germ cell apoptosis. 
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MEHP is a well characterized Sertoli cell toxicant (Thomas et al. 1978; Gray and 
Gangolli 1986; Creasy et al. 1988). It disrupts Sertoli cell function and causes an increase 
in germ cell apoptosis, in both young rats and mice, leading to testicular atrophy (Lee et 
al. 1997; Lee et al. 1999; Giammona et al. 2002). After MEHP-induced Sertoli cell injury, 
only a distinct subclass of germ cells, the primary spermatocytes and early round 
spermatids, undergo apoptosis. Previous work by our laboratory demonstrated that 
increased germ cell apoptosis in response to MEHP in the rat testis was preceded by 
increases in membrane localization of Fas (Richburg et al. 1999). However, the 
mechanisms by which these specific subclasses of germ cells elicit this membrane 
expression of Fas are currently unknown.  
 
The p53 tumor suppressor protein is widely known to influence the transcription 
of the gene for Fas and DR5 in many cell types under conditions of cellular stress (Owen-
Schaub et al. 1995; Muller et al. 1998; Wu et al. 1999; 2000; Takimoto and El-Deiry 
2000). Recently, several investigators have also suggested that the p53 protein may be 
instrumental in the trafficking of Fas to the cell membrane from stores in the Golgi 
complex in a transcription-independent manner (Bennett et al. 1998; Beltinger et al. 
1999). The impetus of the present work was to therefore test the involvement of p53 in 
modulating the sensitivity/membrane localization of Fas in germ cells. MEHP has not 
been implicated in direct injury to germ cells, but instead, through injury to Sertoli cells, 
creates an inhospitable external environment for them (Gray and Gangolli 1986; Chapin 
et al. 1988). We therefore hypothesize that MEHP-mediated Sertoli cell injury may lead 
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to a secondary p53 response by germ cells, resulting in the increased sensitivity of germ 
cells to undergo apoptosis.  
 
Here we demonstrate, using p53 knockout (p53-/-) mice, that the localization of 
Fas and DR5 on the germ cell membrane and the ability of the death receptors to initiate 
apoptosis is, in part, dependent on the expression of p53. Importantly, the changes in Fas 
membrane expression appear to be mediated by p53 in a transcription-independent 
manner. In addition, we also report the novel finding in the testis that p53 influences the 
cellular levels of c-FLIP, a key inhibitory protein of the Fas intracellular signaling 
pathway. These data for the first time suggest an interaction between the death-receptor 
and the internal “stress-sensor” p53 protein in the regulation of testicular germ cell 




3.2.1. P53-/- mice have attenuated rates of MEHP-induced germ cell apoptosis:  
 
Analysis of testicular histology of p53+/+ and p53-/- mice revealed similar minor 
aberrations in the seminiferous epithelium including Sertoli cell vacuoles and germ cell 
sloughing (Fig. 3.1 A-D) that are likely due to the background strain of these mice. 
TUNEL analysis (Fig. 3.1E) showed a biphasic apoptotic response after MEHP exposure 
in both the p53+/+ and p53-/- mice with an early apoptotic peak incidence being reached 
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at 1.5 h and a late peak incidence occurring at 24 h after the acute dose of MEHP. The 
observed second peak of apoptosis matches the results of our earlier work in the C57 
mice (Giammona et al. 2002).  However, tissue had not been collected previously at the 
1.5h time point. The p53+/+ animals show a ~4-fold increase in peak apoptosis at both 
time points, while p53 -/- animals display a ~3-fold increase with respect to their control 
at the same points. A direct comparison of the apoptotic index between the p53+/+ and 
p53-/- mice revealed a significant reduction (~40%) in the incidence of germ cell 
apoptosis in the p53-/- mice at 1h, 1.5h and 24h. In both mouse strains the specific sub-
types of germ cells undergoing apoptosis are the same at all time points (Fig. 3.1 A-D). 
 
3.2.2. Membrane death receptor expression is not up regulated after MEHP in p53-/- 
mice: 
 
 The levels of Fas in testicular membrane preparations reached significantly 
elevated levels by 12h in the p53+/+ animals after MEHP exposure (Fig. 3.2 A,C) and 
remained elevated 0.5 fold above control levels at 24h. In these mice, membrane DR5 
levels were also found to increase within 1.5 h and remain at an elevated levels up to 12 h 
after MEHP exposure (Fig. 3.2 B,D). Increases in membrane Fas and DR5 levels were 
not detected above untreated controls in p53-/- mice (Fig. 3.2 A-D). Basal levels of Fas in 
p53-/- mice were not significantly different from those in p53+/+ mice (Fig. 3.2 A). 





Fig. 3.1.  Attenuation of germ cell apoptosis in p53-/- mice after MEHP exposure. 
(A-D) Cross sections of testes collected from p53+/+ (A,B) and p53-/- (C,D) mice 
counterstained with hematoxylin for TUNEL analysis. Scale bars for A,C =50µm, and for 
B,D =100µm. Sertoli cell vacuoles (asterisks) and sloughed germ cells (arrow heads) 
observed in the seminiferous tubules of both p53+/+ and p53-/- mice. TUNEL positive 
(brown cells) round spermatids (larger arrows) and primary spermatocytes (smaller 
arrows) are indicated. (E) Apoptotic index was calculated as described in the Materials 
and Methods. Values represent the mean ± SEM.  ‘a’ denotes significant differences 
(p<0.1) in apoptotic index between untreated and MEHP-treated mice of the same strain, 
‘b’ denotes significant differences (p<0.1) between p53-/- and p53+/+ mice at matched 































Fig. 3.2.  Western blot analysis of Fas and DR5 in membrane fractions of testicular 
homogenates. Representative blots from 4 testicular samples for each time point are 
provided. (A) Fas (~44 kDa) band intensity and (C) graphical representation of 
densitometric analysis in the p53+/+ and p53-/- mice exposed to MEHP. (B) DR5 (~49 
kDa) band intensity and (D) graphical quantitation in the p53+/+ and p53-/- mice exposed 
to MEHP. Values represent the mean ± SEM. ‘a’ denotes significant differences (p<0.1) 
in membrane death receptor levels between untreated and MEHP-treated mice of the 
same strain, ‘b’ denotes significant differences (p<0.1) between p53-/- and p53+/+ mice 






























































3.2.3. The presence of p53 does not cause transcriptional up-regulation of death receptors 
in response to MEHP:  
 
 Fas  mRNA levels were evaluated in testicular samples of animals at various time 
points after MEHP exposure using semi-quantitative RT-PCR. After toxicant exposure, 
no significant changes are observed in the Fas mRNA expression in both p53+/+ and 
p53-/- animals (Fig 3.3 A,B). RT-PCR results for Fas for each time point is normalized 
with β-actin. Similar analyses of DR5 mRNA levels revealed an absence of transcription 
after MEHP exposure in both p53+/+ and p53-/- mice (Fig. 3.3 C).  
 
3.2.4.  MEHP exposure does not lead to caspase-8 cleavage in p53-/- animals: 
  
Procaspase-8 cleavage is a hallmark indicator of death receptor activation. Murine 
procaspase-8 is known to be efficiently cleaved to fragments of ~44 kDa, ~31 kDa (dimer 
of the 18kDa and 10kDa subunits), ~20 kDa and ~10 kDa sizes (Van de Craen et al. 
1998). Here we measured the formation of both the 44 kDa (Fig. 3.4 A,B) and 31 kDa 
(data not shown) fragments as detected by western blot analysis of total testis 
homogenates of p53+/+ and p53-/- mice exposed to MEHP.  In both mouse strains, 
untreated control animals express measurable amounts of the processed forms. A 
significant increase in the 44 kDa processed form of caspase-8 is measured in the p53+/+ 
mice at 1h, 1.5h, 3h, and 24h after MEHP treatment (Fig. 3.4 A,B). However, no 
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Fig. 3.3.  Semi-quantitative RT-PCR analysis of testicular Fas and DR5 mRNA 
levels after MEHP exposure and Western analysis of total cellular Fas protein. 
Representative gels for Fas mRNA (A) and DR5 (C) in p53+/+ and p53-/- mice, and 
graphical representation of densitometric analysis (B), represent the results of 3 
experiments. β-actin is used as an internal control. Values are mean ± SEM. No 
significant changes are observed. (D) Representative blots of total cellular samples from 
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significant differences with respect to untreated controls are observed in the p53-/- mice 
(Fig. 3.4 A,B). 
 
3.2.5. c-FLIP protein levels are increased only in p53-/- mice, while mRNA levels change 
similarly in both p53+/+ and p53-/- mice: 
 
 Western blot analysis of total testis homogenates was carried out to analyze 
changes in c-FLIP (L) and (S) forms after MEHP treatment.  While no significant 
changes in c-FLIP (L) and (S) protein levels were observed in the p53+/+ mice (Fig. 3.5 
A,C), increased expression of both forms was measured in the p53-/- animals; c-FLIP (L) 
(Fig. 3.5 B,C) and (S) levels (Fig. 3.5 B) were enhanced (~2-5 fold) in p53-/- mice as 
early as an hour after toxicant exposure. In the p53-/- mice, c-FLIP (L) levels were 
significantly higher than treatment controls at 1.5h, 3h and 6h after MEHP exposure and 
a significant difference between corresponding c-FLIP (L) levels in p53+/+ and p53-/- 
mice were observed at these time points as well. Evaluation of mRNA levels of c-FLIP 
(L) shows similar basal levels and no significant changes in the transcriptional regulation 




Previous work from our laboratory established the participation of the Fas/FasL 
signaling system in the initiation of testicular germ cell apoptosis after exposure of 
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Fig. 3.4. Procaspase-8 processing in response to MEHP exposure. Representative 
blots (A) for the ~44 kDa processed form of caspase-8 in p53+/+ and p53-/- mice after 
exposure to MEHP. Graphical representation (B) of the densitometric analysis for the 44 
kDA form of caspase-8, normalized for actin, from 4 testicular samples per time point. 
Values are mean ± SEM. ‘a’ denotes significant differences (p<0.1) in processed caspase-
8 levels between untreated and MEHP-treated mice of the same strain, ‘b’ denotes 







































Fig. 3.5.  Western blot analysis of c-FLIP protein levels in response to MEHP 
exposure. Representative blots for c-FLIP (L) (55 kDa) and c-FLIP (S) (28 kDa) from 
p53+/+ (A) and p53-/- (B) mice exposed to MEHP. (C) A graphical representation of 
densitometric analysis of c-FLIP (L) levels from 3 experiments, normalized for actin. 
Values are mean ± SEM. ‘a’ denotes significant differences (p<0.1) in c-FLIP (L) levels 
between untreated and MEHP-treated mice of the same strain, ‘b’ denotes significant 
differences (p<0.1) between p53-/- and p53+/+ mice at matched time points. 
0h    1h      1.5h   3h      6h     12h 0h      1h    1.5h    3h      6h     12h 
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Fig. 3.6.  Semi-quantitative analysis of c-FLIP (L) mRNA levels by RT-PCR after 
MEHP exposure. Representative gels for c-FLIP (L) mRNA from p53+/+ (A) and p53-/- 
(B) mice exposed to MEHP, and graphical representation of densitometric analysis (C), 
represent the results of 3 experiments. β-actin is used as an internal control. Values are 





































 rodents to the Sertoli cell toxicant MEHP (Lee et al. 1997; Lee et al. 1999). FasL 
expressed by Sertoli cells appears to interact with Fas expressed by a specific subset of 
germ cells to trigger their apoptotic demise. In our previous investigations it was clear 
that the expression of Fas on the germ cell membrane was a prerequisite for their 
sensitivity to apoptosis (Richburg et al. 1999). However, the mechanisms by which germ 
cells increase their surface expression of Fas have not been established. A novel 
observation of the dependence of the p53 protein in the trafficking of Fas to the cell 
membrane in human vascular smooth muscle cells has been described (Bennett et al. 
1998). The participation of the p53 tumor suppressor protein in the modulation of 
apoptosis is widely described to occur by several well-known mechanisms involving the 
cell cycle protein p21, and the modulation of the transcriptional expression of various 
pro-apoptotic genes including PUMA, NOXA, Bax, DR5, PIG3 and even Fas in some 
cells (el-Deiry et al. 1993; Miyashita and Reed 1995; Polyak et al. 1997; Munsch 2000; 
Takimoto and El-Deiry 2000; Villunger et al. 2003). In the present study we aimed to 
investigate whether p53-deficient mice displayed alterations in their surface membrane 
expression of Fas and whether these mice would be less sensitive to the MEHP-
stimulated loss of testicular germ cells. 
 
 The p53-/- mice used in this study showed only minor alterations in testicular 
histology (Fig. 3.1 C,D). However, these minor changes in the seminiferous epithelium 
appeared to be due to the background strain of these mice (C57/129S/v) since the paired 
wild-type mice displayed similar changes in the seminiferous epithelium (Fig. 3.1 A,B). 
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Comparison of wild-type p53+/+ versus p53-/- mice testes after MEHP exposure revealed 
a trend of lowered germ cell apoptosis after MEHP exposure in p53-/- mice (Fig. 1E). 
However significant decreases (~ 40%) in apoptosis in the p53-/- mice were only 
measured at 1h, 1.5h and 24h. Because these time points corresponded to the two peaks 
of apoptosis seen in p53+/+ mice, the difference in the sensitivity of these mice was 
perhaps easier to resolve.  Interestingly, the germ cell subtypes undergoing apoptosis in 
response to MEHP exposure were the same for both the p53+/+ and p53-/- mice (Fig. 3.1 
A-D). In our previous studies examining the sensitivity of gld mice to MEHP-induced 
germ cell apoptosis, we demonstrated a significant protection from apoptosis beginning 
as early as 6 h after exposure with maximal decreases (~50%) in apoptosis observed 12 
and 24 h after MEHP exposure (Richburg et al. 2000; Giammona et al. 2002). Although 
our present findings in the p53-/- mice do not reveal a similar robust protection as that 
seen in gld mice, it does reveal that p53 plays at least a partial role in modulating the 
MEHP-stimulated germ cell apoptosis.  
 
Based on the findings of Bennett (Bennett et al. 1998) and Beltinger (Beltinger et 
al. 1999), we predicted that p53-/- mice would display reduced membrane levels of Fas 
and would not show large increases after MEHP exposure. We show that p53-/- mice 
display high basal membrane expression levels of Fas (but not statistically different from 
levels in p53+/+ mice) in the testis (Fig. 3.2A). In accordance with our predictions, after 
MEHP exposure, increases in membrane Fas were only observed in p53+/+ mice (Fig. 
3.2 A,C). These findings may explain, in part, the observed attenuation of MEHP-
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induced germ cell apoptosis in p53-/- mice. However, the abundant basal levels of Fas 
expression that are observed may account for the germ cell apoptosis that does occur.  
 
In the present work we show that DR5, another death receptor whose expression 
is modulated by p53 activation, is abundantly expressed in p53-/- mice. Similar to the 
observations of Fas expression in p53-/- mice after MEHP exposure, DR5 membrane 
levels did not increase in p53-/- mice (Fig. 3.2 B,D). However, DR5 membrane 
expression was abundantly up-regulated in p53+/+ mice as early as 1.5 hours after MEHP 
exposure and was maintained at high expression levels through 12 h.  Although the 
expression profile of DR5 correlated very well with the first phase of caspase-8 activation 
as well as germ cell apoptosis in p53+/+ mice after MEHP exposure, the ability of the 
DR5/ TRAIL system to initiate cell death in normal tissues is unresolved (Jo et al. 2000; 
Nesterov et al. 2002; Almasan and Ashkenazi 2003). Future investigations will therefore 
be aimed at functional studies to test TRAIL’s ability to instigate germ cell apoptosis in 
the testis. However, our data do indicate that Fas and DR5 are expressed in p53-/- mice, 
although their ability to be increased on the membrane after MEHP exposure and 
increase germ cell sensitivity is severely limited.  
 
Our initial interest at assessing the p53 protein as a likely modulator of Fas was 
based upon p53’s reported ability to cause membrane trafficking of Fas by a 
transcription-independent mechanism (Bennett et al. 1998; Beltinger et al. 1999). In 
support of this idea, we found that Fas mRNA levels in the testis of p53+/+ mice did not 
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significantly increase after MEHP exposure (Fig. 3.3 A,B). We were also unable to detect 
significant changes in the total Fas protein levels in the wild type p53+/+ mice after 
MEHP exposure (Fig 3.3 D). Therefore, the increased levels of Fas receptor in the 
membrane preparations of p53+/+ mice at 6h and 12h after MEHP are not due to the 
increased expression of the protein via transcription. Although the testicular membrane 
preparations used in our experiments are comprised of membranes of sub-cellular 
organelles as well as the plasma membrane of these cells, changes in Fas protein levels 
from Golgi and ER do not likely account for the observed changes in total membrane 
levels since any increases in Fas protein in these organelle membranes reflects the 
production of new protein; a process which is not increased as evidenced by the absence 
of significant increases in both Fas mRNA and total protein levels. Our observations that 
Fas levels are not increased in the testicular cell membrane preparations of p53-/- mice 
after MEHP exposure supports the hypothesis that functional p53 is required for Fas 
protein transport from Golgi or other intracellular storage sites to the membrane. Another 
intriguing result is the absence of increased DR5 transcription (Fig. 3.3 C) in both 
p53+/+ and p53-/- mice after MEHP exposure. These observations indicate the absence 
of active transcription by p53 in the testis, even of a robustly transcribed p53 gene DR5, 
after MEHP treatment. 
 
To further investigate whether death receptors are activated in p53-/- mice, we 
evaluated procaspase-8 processing. Caspase-8 is autocatalytically processed from its pro-
form to active form at the DISC (Muzio et al. 1996), which is created only when Fas is 
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activated. We observed the formation of the 44 kDa (Fig. 3.4 A) and ~31 kDa (data not 
shown) processed forms of caspase 8. The baseline levels of these processed forms are 
similar between the p53+/+ and p53-/- mice. However, following MEHP exposure, 
statistically significant increases in the level of the 44 kDa form of caspase 8 (Fig. 3.4 B) 
and in the 31kDa form (data not shown) were observed only in the p53+/+ mice, 
demonstrating a more robust activation of Fas in animals expressing p53. Moreover, the 
formation of enhanced levels of active caspase-8 that preceded the two major apoptotic 
peaks in our wild type mouse exposed to MEHP supports our earlier reports implicating 
Fas activation in MEHP-mediated germ cell apoptosis. The outcome of these experiments 
supports our hypothesis; death receptor activation in mice exposed to MEHP is p53-
dependent.  
 
The absence of p53 did not drastically reduce the basal membrane expression 
levels of Fas, though it may be responsible for the inability of Fas levels to increase on 
the membrane in response to MEHP exposure. However, these basal membrane levels of 
Fas could be sufficient for triggering germ cell apoptosis that we do observe. Therefore, 
the attenuation of apoptosis in p53-/- mice may be due to other modulators of the death 
receptors’ activity. The Fas activated pathway can be inhibited by the cellular FLICE 
inhibitory protein (c-FLIP), which contains two death effector domains and can bind 
FADD (Irmler et al. 1997). Mammalian cells express two splice variants of c-FLIP, c-
FLIP long (L) and c-FLIP short (S), which can function to inhibit death receptor 
mediated apoptosis (Krueger et al. 2001) by inhibiting caspase-8 activation. c-FLIP (L) 
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lacks a cysteine at the active site of its protease domain and inhibits apoptotic signaling 
by only allowing partial processing of procaspase-8, while c-FLIP (S) lacking the 
protease domain, merely binds at the DISC to completely prevent procaspase-8 
processing (Irmler et al. 1997; Krueger et al. 2001). It has been reported that c-FLIP 
protein can be degraded in cancer cells in a p53-dependent manner (Fukazawa et al. 
2001). In addition, c-FLIP expression has been reported in mouse testis and has been 
implicated in protecting the immortalized germ cell line, GC-1spg, from Fas-mediated 
apoptosis (Giampietri et al. 2003). Therefore, we evaluated if changes in c-FLIP protein 
levels in the testes occurred in both the p53+/+ and p53-/- mice following MEHP 
exposure and correlated with the sensitivity of germ cells to undergo apoptosis. In the 
p53+/+ mice, the levels of c-FLIP (L and S) protein were similar and unchanged after 
MEHP-treatment while c-FLIP (L and S) levels significantly increased in p53-/- mice 
after MEHP exposure (Fig. 3.5 A-C). Analysis of c-FLIP (L) mRNA levels revealed 
similar transcriptional profiles of c-FLIP (L) in response to MEHP toxicity, regardless of 
p53 status (Fig. 3.6 A-C). The absence of c-FLIP protein up regulation in response to 
MEHP in p53+/+ mice, despite comparable transcription in both mouse models suggests 
that c-FLIP may be degraded much more rapidly in the p53+/+ mice as has been 
suggested before (41). This is also supported by the enhanced Fas/c-FLIP ratio in the 
p53-/- mice (data not shown). It is plausible that 2-5 fold higher levels of c-FLIP in the 
p53-/- mice may be responsible, in part, for the reduced caspase 8 processing observed 
despite their having high Fas membrane levels.   
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In the present study we have made the following novel observations: 1) The 
absence of p53 expression correlates with an attenuation of germ cell apoptosis after 
MEHP exposure, 2) MEHP-induced increases in the membrane levels of Fas and DR5 
occurs only in p53+/+ mice, 3) p53 mediates increased membrane levels of Fas on germ 
cell membranes in response to MEHP in a transcription-independent manner, 3) MEHP-
induced caspase-8 processing is enhanced in the testis of p53+/+ mice but not in p53-/- 
mice and, 5) Attenuation of MEHP-triggered germ cell apoptosis in p53-/- mice 
correlates with increased testicular c-FLIP protein levels. Taken together, these findings 
indicate that p53 may play a multi-tiered role in MEHP-induced germ cell apoptosis. The 
p53 protein not only serves to promote death receptor membrane localization, but by 
bringing about the degradation of c-FLIP, p53 may act to ensure that Fas can be 
maximally activated in germ cells in response to MEHP-induced testicular injury. 
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Chapter 4:  The influence of p53 status on Fas membrane localization, c-FLIP 
ubiquitinylation and sensitivity of testicular germ cells to undergo Fas-
mediated apoptosis 
 
4.1. Introduction and Rationale 
 
 We demonstrated a potential mechanism by which the activation of Fas and/or 
DR5 in germ cells in vivo is modulated in response to MEHP. The p53 protein mediates 
death receptor membrane localization and also alters the protein levels of c-FLIP (L) in 
this toxicant injury model. Interestingly, only after exposure to MEHP do the p53 -/- mice 
express very high levels of c-FLIP (L). The p53 protein influences the degradation of the 
c-FLIP protein via the process of ubiquitinylation in colon cancer cells (Fukazawa et al. 
2001). Ubiquitinylation is the process by which intracellular proteins in eukaryotes are 
targeted for degradation (Ciechanover et al. 2000). Proteins conjugated with four or more 
ubiquitin molecules, enables their recognition and subsequent cleavage by the 
proteasome (Jan-Michael Peters and Robin Harris 1998). We demonstrated that the p53 
status of the mice affected only the protein levels of c-FLIP and not their mRNA levels.  
Therefore we hypothesized that death receptor activated apoptotic pathway in germ cells 
could be affected by the modification of protein levels of c-FLIP (L) perhaps by 
ubiquitinylation, and in a p53-dependant manner. To further characterize the involvement 
of p53 in the sensitivity of germ cells to Fas- and/or DR5 mediated apoptosis, we utilize 
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the transformed germ cell line called GC-2spd (ts) that has a temperature sensitive 
expression of p53.  
 
Germ cell-2 spermatid (temperature sensitive) cells or GC-2spd (ts) cells were 
originally created by Hofmann (Hofmann et al. 1994) to study the process of germ cell 
differentiation. These cells were created by transforming preleptotene spermatocytes 
from 6 week old BALB/c mice, using the SV40 virus’ large T antigen and co-transfecting 
them with a plasmid carrying a p53 mutant gene (p53Val-135). The mutant p53 protein is 
fully active at 32 ºC but completely inactive at 39 ºC and only partially active at 37 ºC 
due to improper folding of the protein that inhibits its nuclear localization. Therefore, by 
modulating the temperature at which GC-2 cells grow, we could functionally create 
p53+/+ or p53 -/- germ cells. Furthermore, this cell line is an appropriate in vitro model 
since these cells were derived from spermatocytes; which is the germ cell type most 
sensitive to apoptosis after toxicant-induced Sertoli cell injury. 
 
Since germ cells are not the direct targets of MEHP (Gray and Gangolli 1986), in 
the present work we use the anti-Fas antibodies (JO2) or human TRAIL ligand to mimic 
the contribution of Sertoli cell FasL/TRAIL and elicit germ cell apoptosis. Here we report 
a p53- dependent increase in membrane Fas expression in GC-2 cells maintained at 32 ºC 
and increased sensitivity to JO2 treatment only at this p53 permissive temperature.  
However, no significant differences in DR5 membrane levels are reported between the 
cells grown at the p53 permissive and non-permissive temperatures.  Additionally, 
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increased sensitivity to TRAIL was only observed in the presence of non-toxic 
concentrations of the protein synthesis inhibitor, cycloheximide in cells at the p53 
permissive temperature.  
 
At the non-permissive p53 temperature, GC-2 cells expressed higher levels of c-
FLIP (L) protein in response to JO2 and decreasing the amounts of c-FLIP via an siRNA 
approach re-sensitized these cells to JO2-induced apoptosis. The siRNA transfected cells 
were however, not sensitized to TRAIL treatment. We also demonstrate a robust increase 
in the ubiquitinylation of c-FLIP (L) at the p53 permissive temperature implying an 
active degradation mechanism for c-FLIP within these cells. These findings demonstrate 
that the GC-2 system can be used to successfully model death receptor-activated germ 
cell apoptosis and is useful for the study of the dynamics between the death receptors and 




4.2.1. Expression profile of various apoptotic proteins in GC-2 cells based on p53 
activation status: 
 
 Immunocytochemistry was performed to determine the cellular localization of 
p53 at different temperatures. As shown in Fig. 4.1 A (i-ii), p53 localized entirely in the 
nucleus at the permissive temperature of 32 ºC (Fig. 4.1 A, ii), while being expressed in  
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Fig. 4.1. Expression profile of apoptotic proteins in GC-2 cells. (A) Representative 
images of p53 (i, ii) and Fas (iii-vi) stained GC-2 cells at both the non-permissive (37 ºC) 
(i, iii, v) and permissive (32 ºC) (ii, iv, vi) p53 temperatures. GC-2 cells were either 
treated with JO2 (v, vi) or untreated (iii,iv) before being immunostained for Fas. Cells 
were immunostained with primary antibodies against p53 or Fas and secondary 
antibodies conjugated to FITC. (B) (C) Representative western blots for Fas (in 
membrane fraction), c-FLIP(L) and (S), and p21 are shown here from cells grown at both 
the non-permissive and permissive p53 temperatures. The data represent results from 3 
independent experiments. 
















both cytosolic and nuclear compartments when grown at 37 ºC (i). These results are 
similar to those demonstrated previously (Hofmann et al. 1994). Fas expression in GC-2 
cells was also analyzed by ICC and by western blot analysis of membrane fractions of 
these cells. Fas was detected by ICC in cells grown at both temperatures, with cells at 32 
ºC expressing abundant amounts of Fas (Fig. 4.1 A, iii-iv). Cells grown at both 
temperatures showed punctuate Fas staining in response to exposure to JO2 (Fig. 4.1 A, 
v-vi). The Fas membrane expression profile as determined by western blots, was equally 
different between the two cell types, with a 8-10 fold increase in the membrane Fas levels 
in cells at 32 ºC over those grown at 37 ºC (Fig. 4.1 B). However, the levels of DR5 in 
membrane fractions of the two cell types were found to be similar (data not shown). The 
activation of p53 at 32 °C, and not at 37 ºC is demonstrated by the levels of the p53 
transcription product p21, as cells grown at 32 °C show abundant expression of the p21 
protein while those at 37 ºC do not (Fig. 4.1 B). c-FLIP (L) and (S) were also found to be 
expressed in GC-2 cells at both temperatures and at comparable levels (Fig. 4.1 B).  
 
4.2.2. GC-2 cells are insensitive to MEHP treatment, while sensitivity of GC-2 cells to 
anti-Fas (JO2) and TRAIL treatment is dependent on p53 activation  
 
GC-2 cells grown at 37 ºC and 32 ºC were exposed to 200 µM MEHP for up to 24 
hours in order to confirm that MEHP does not act directly on germ cells and instigate 
their demise. Analysis of incidence of cellular apoptosis in these cells by flow cytometry 
using the Annexin V-PI assay, revealed no increases in cell death in GC-2 cells after 
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Fig. 4.2. Analysis of apoptosis levels in GC-2 cells by Annexin-PI assay after 
exposure to MEHP or JO2 or TRAIL. (A) A graphical representation of annexin 
positive GC-2 cells at the non-permissive p53 temperature and (B) at the permissive p53 
temperature, after exposure to MEHP, DMSO or matched time point controls. (C). A 
graphical representation of annexin positive GC-2 cells at the non-permissive p53 
temperature and (D) at the permissive p53 temperature, after exposure to JO2, Hamster 
IgG or matched time point controls.  (E). A graphical representation of annexin positive + 
annexin and PI positive GC-2 cells at the non-permissive p53 temperature and (D) at the 
permissive p53 temperature, after exposure to human TRAIL, cycloheximide (ChX), 
cycloheximide + TRAIL or matched time point controls.  The data represent results from 
3 independent experiments (except results on panel E- they represent data from 2 
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exposure to MEHP or DMSO vehicle control (Fig. 4.2 A,B). These results were obtained 
from three independent groups of experiments. 
 
 Earlier results indicated that transferring GC-2 cells to a lower temperature not 
only activated p53 but also caused a substantial increase in membrane Fas levels in these 
cells. Flow cytometric analysis of annexin V-PI stained cells indicates that GC-2 cells at 
the p53 permissive temperature display a near 5-fold increase in cell death (15-20% 
annexin positive cells compared to 2-4 % positive stain for control cells) by 24 h after 
exposure to JO2 (Fig. 4.2 C,D). Cells grown at the non-permissive p53 temperature were 
not killed upon exposure to JO2. Cells grown at either temperature were also not 
responsive to the presence of hamster IgG, an isotype control for the JO2 antibody. 
 
 Cells were exposed to human TRAIL ligand in the presence or absence of a 
protein synthesis inhibitor, cycloheximide. The cytotoxicity of cycloheximide is evident 
even at 10 µM in cells at 37 ºC, while a higher dose of 100 µM is the cytotoxic dose in 
cells at 32 ºC. Only cells at the p53 permissive temperature however, demonstrate 
increased levels of apoptosis (as demonstrated by flow cytometric analysis of annexin 
and annexin-V + PI stained cells, Fig. 4.2 E,F) in the presence of TRAIL and the non-
toxic dose of cycloheximide. These cells do not undergo enhanced cell death in response 




4.2.3. p53 status of GC-2 cells determines the protein expression levels of c-FLIP (L) in 
response to anti-Fas treatment, but not mRNA levels: 
 
 Western blot analysis of c-FLIP (L) levels in GC2 cells treated with JO2 show 
that c-FLIP (L) levels are elevated by 3-fold in GC2 cells grown at 37 ºC at both 3 and 6  
h after exposure, while they remained below control levels in cells at 32 ºC (Fig. 4.3 A). 
Real-time PCR assessment of c-FLIP (L) transcription in response to JO2 addition 
revealed that cells grown at both temperatures do not demonstrate any significant changes 
in their c-FLIP(L) mRNA levels at any time point after JO2 treatment (Fig. 4.3 B, i, ii). 
Direct comparison of c-FLIP (L) mRNA levels of control samples at 32°C and 37°C 
indicate that at 32°C GC-2 cells express approximately 0.6 fold more c-FLIP (L) mRNA 
as compared to cells at 37°C.   
 
4.2.4. Transfection of GC-2 cells with siRNA against c-FLIP (S/L) leads to reduced c-
FLIP (L) mRNA levels, decreased protein expression and increased sensitivity to anti-Fas 
treatment, but not to TRAIL exposure: 
  
 Levels of c-FLIP (L) mRNA were analyzed using semi-quantitative RT-PCR at 
24 h, 30 h and 48 h after c-FLIP siRNA transfection in cells grown at 37 ºC. A reduction 
in mRNA levels by about 50-60 % (normalized to β-actin) was observed at the 24 h time 
point (Fig. 4.4 A). However, the reduction was not maintained beyond this time point, 
with mRNA levels returning to baseline levels by 30 h. Comparisons of c-FLIP (L)  
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Fig. 4.3. Western blot analysis of c-FLIP(L) protein levels, and real-time PCR 
analysis of mRNA levels in response to JO2 treatment (A) Representative blots from 3 
samples for each time point are provided; c-FLIP(L) (~55 kDa) bands and actin (~43 
kDa) are shown here for cells grown at both 37 ºC and 32 ºC temperatures after JO2 
treatment, with their matched time controls. ‘C’ represents controls, ‘J’ represents JO2 
treated cells. The net intensity of c-FLIP (L) expression as a percent of untreated matched 
time control and normalized to actin are indicated above each treated sample. (B- i and ii) 
A graphical representation of relative expression levels (relative to the same calibrator) of 
c-FLIP (L) mRNA (from 3 samples for each time point) with or without JO2 treatment at 
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mRNA levels were made against control siRNA transfected cells, as well as with cells 
that had not undergone transfection .  At 48 h after transfection, we were able to 
demonstrate a significant reduction in c-FLIP (L) protein levels by western blot analysis 
(60-80 % reduction) in siRNA transfected cells, compared to corresponding controls (Fig. 
4.4 B). 
 
GC-2 cells at the non-permissive temperature of 37 ºC and transfected with 
siRNA for c-FLIP, were exposed to anti-Fas or TRAIL treatment. Cells exposed to JO2 
underwent a 4-fold increase in apoptosis levels compared to matched time controls at 
both 6 and 12 h after exposure, as determined by flow cytometric analysis of annexin-
positive cells (Fig. 4.4 C).  However cells exposed to TRAIL remained insensitive to its 
effects, despite the reduction in c-FLIP (L) levels (data not shown). 
 
4.2.5. Ubiquitinylation of c-FLIP in GC-2 cells is increased when p53 is active and after 
exposure to JO2: 
 
To determine if c-FLIP undergoes post-translational modification by ubiquitin, c-
FLIP was immunoprecipitated from lysates of GC-2 cells following exposure to JO2. The 
complexes collected through this procedure showed significant differences by western 
blot analysis in levels of the ubiquitin-tagged c-FLIP between cells at the p53 permissive 




Fig. 4.4. Analysis of c-FLIP(L) mRNA and protein levels, and apoptotic levels in 
response to JO2 after knockdown of c-FLIP(L) by siRNA. (A) Representative gels for 
c-FLIP (L) mRNA from GC-2 cells at the non-permissive p53 temperature exposed to c-
FLIP siRNA for 24h, 30h and 48h. β-actin is used as an internal control. ‘C’ represents 
controls, ‘CS’ represents control siRNA treated cells and ‘F’ represents c-FLIP siRNA 
treated cells. (B) Representative western blots are provided; bands for c-FLIP(L) (~55 
kDa) and actin (~43 kDa) are shown here for cells grown at the non-permissive p53 
temperature, transfected with control siRNA (CS), c-FLIP siRNA (F) or matched time 
controls (C) at 48 h post transfection. (C) A graphical representation of annexin positive 
GC-2 cells +/- c-FLIP siRNA transfection and exposed to JO2, or their matched time 
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Fig. 4.5. Immunoprecipitation analysis of ubiquitinylation of c-FLIP(L) in GC-2 
cells exposed to JO2. (A) ) Representative blots from 3 samples for each time point are 
provided; protein complexes bound to c-FLIP were probed for ubiquitin tag in cells 
grown at both 37 ºC and 32 ºC and exposed to JO2. Lanes 1-3 represent samples at the 
non-permissive temperature treated with JO2, while lanes 4-6 represent samples from 
cells at the permissive p53 temperature also exposed to JO2 for indicated time periods. 
(B) Representative blots from 3 samples for each sample are provided; Lysates from the 
pull-down assay were probed for c-FLIP(L) at 6h after JO2 exposure. ‘C’ represents 
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revealed as a collection of bands (molecular weight of 83 kDa to 98 kD) on the western 
blot that corresponded to the predicted mass of c-FLIP (L) plus ubiquitin. 
Polyubiquitinylated levels of c-FLIP were low in GC-2 cells grown at the p53 non-
permissive temperature but were at readily detectable levels after JO2 addition (Fig. 4.5 
A, lanes 1-3). Cells cultured at the p53 permissive temperature exhibited a higher basal 
level of ubiquitinylation which also increased 3 h after JO2 treatment (Fig. 4.5 A, lanes 
4-6). Interestingly, at 6 h after JO2 exposure, the levels of the polyubiquitin labeled c-
FLIP complex had already begun to decline in these cells. Immunoprecipitated 
complexes were also probed using the anti-c-FLIP rat monoclonal antibody. c-FLIP (L) 
was similarly expressed in both cell types in the absence of JO2 treatment. With the 
addition of JO2, three or more protein bands approximately 8.5 kDa apart in addition to 
the naïve c-FLIP protein band were generated, corresponding to the sizes expected for 
ubiquitin tagged c-FLIP protein (Fig. 4.5 B). The data show a reduction in 
ubiquitinylated c-FLIP by 6 h after JO2 exposure at the p53 permissive temperature, 




 In general, depending upon the physical injury or chemical toxicant that the testis 
is exposed to, germ cell apoptosis is initiated by either the activation of the death receptor 
pathway or via activation of the stress response pathway involving the mitochondrial 
release of cytochrome c (Lee et al. 1997; Lee et al. 1999; Embree-Ku et al. 2002; Vera et 
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al. 2004). Sertoli cell injury mediated by the active phthalate monoester, MEHP, results 
in the death of germ cells through the paracrine interaction of Sertoli cell produced FasL 
with Fas expressed on germ cells (Richburg et al. 1999). Our previous work in vivo 
demonstrated a role for p53 in Fas receptor membrane localization as a late event in 
response to MEHP, and in DR5 membrane localization as well (Chandrasekaran and 
Richburg 2005). In addition, we have shown that the activation of the death receptor 
pathway (as indicated by procaspase-8 processing) in testicular germ cells was abrogated 
in mice lacking the expression of p53, a condition that may be directly linked to the 
increased expression of c-FLIP (L). These findings in vivo led us to hypothesize that the 
c-FLIP (L) protein is modified in a p53-dependent manners in germ cells after death 
receptor activation. The p53 protein is a transcription factor that in many cell types 
causes the up-regulation in levels of pro-apoptotic proteins, such as Bax, Puma, Noxa, 
Fas, DR5, etc (Miyashita and Reed 1995; Munsch 2000; Takimoto and El-Deiry 2000; 
Villunger et al. 2003). Therefore, the aim of the present in vitro work with GC-2 cells 
was to functionally characterize the relationships between Fas, DR5, p53 and c-FLIP in 
germ cell apoptosis. 
 
 GC-2 cells were originally created to provide an in vitro model of germ cell 
differentiation (Hofmann et al. 1994). GC-2 cells were created from spermatocytes that 
had been immortalized with the SV40 virus’s large T antigen and co-transformed with a 
mutant p53 protein. The p53 protein is activated by proper folding and nuclear 
localization at the lower temperatures in GC-2 cells, where it binds the large T antigen 
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and suppresses its proliferative ability. This enables the cells to undergo differentiation. 
However, two years after establishing the GC-2 cell line, the authors were unable to 
detect markers for the various differentiated germ cell types, in cells grown at the p53 
permissive temperature (32 ºC) (Wolkowicz 1996). The cells were therefore deemed 
unsuitable for further studies. However, here we show that these cells serve as a suitable 
model to study apoptosis, due to their differential p53 activity based on the temperature 
they are maintained at. Moreover, GC-2 cells were found to express Fas, DR5 and c-FLIP 
(L) as shown by western blot analyses, or ICC (Fig. 4.1 A,B). 
 
 GC-2 cells were created from spermatocytes, the germ cell sub-type most 
sensitive to MEHP induced apoptosis (Richburg et al. 1999). However, MEHP does not 
act directly on germ cells to mediate their apoptotic demise, rather, MEHP-induced germ 
cell apoptosis occurs indirectly via Sertoli cell expressed FasL activating germ cell Fas 
receptors. Therefore, as expected, we were unable to observe increases in the incidence of 
apoptotic GC-2 cells following exposure to MEHP at either the p53 permissive or non-
permissive temperatures (Fig. 4.2 A,B). In the present study, we used the Fas agonistic 
antibody, JO2, to mimic in vitro the elucidation of FasL by Sertoli cells and the activation 
of Fas-dependent germ cell apoptosis. The JO2 antibody has been shown to efficiently 
trigger apoptosis in murine cells expressing the Fas receptor (Ogasawara et al. 1993). 
GC-2 cells expressed nearly 10-fold more Fas protein on the cell membrane at the p53 
permissive temperature compared to the cells at the non-permissive temperature (Fig. 4.1 
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B) and could easily account for the sensitivity of GC-2 cells maintained at 32 ºC to JO2-
induced apoptosis (Fig. 4.2 D).  
 
 On the other hand, we were unable to demonstrate that GC-2 cells were sensitive 
to TRAIL treatment (Fig. 4.2 E,F). The membrane DR5 levels in both cell types 
remained unchanged (data not shown) despite the differences in p53 status. This could 
perhaps account for the similar responses to TRAIL by cells at both temperatures. 
Despite TRAIL’s ability to kill cancer cells, the sensitivity of normal cells to TRAIL 
treatment has been disputed over the years, although the susceptibility of normal 
hepatocytes (Jo et al. 2000), normal prostate epithelial cells (Nesterov et al. 2002) and 
thymocytes (Simon et al. 2001) to TRAIL treatment have been demonstrated. TRAIL has 
also been implicated in mediating cell survival of primary vascular endothelial cells by 
activating the ERK pathway (Secchiero et al. 2003). Thus, the absence of an apoptotic 
response to TRAIL by GC-2 cells demonstrates that TRAIL may not promote germ cell 
death and hence DR5 may not have a role in MEHP induced germ cell apoptosis. 
Additionally, we have used the human form of the TRAIL ligand for our experiments. 
Human TRAIL is nearly 70 % homologous to its mouse form and could potentially not 
be useful to kill murine cells thereby explaining our results. However, cells at the p53 
permissive temperature could be sensitized to TRAIL treatment in the presence of the 
protein synthesis inhibitor cycloheximide (Fig. 4.2 F). Further studies are necessary to 
explore the sensitivity of GC-2 cells to the murine form of TRAIL and to clarify the issue 
beyond doubt.  
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Cycloheximide can sensitize cells to TRAIL mediated apoptosis by causing a 
reduction in c-FLIP protein levels (Kreuz et al. 2001; Brooks and Sayers 2005). 
Additionally, the over-expression of c-FLIP (L) is responsible for inhibiting TRAIL- 
induced apoptosis in prostate cancer and malignant mesothelial cells (Rippo et al. 2004; 
Zhang et al. 2004). Thus c-FLIP siRNA transfected GC-2 cells at the non-permissive p53 
temperature were also exposed to TRAIL to determine if the lack of TRAIL sensitivity in 
these cells was due to inhibition of DR5 activation by c-FLIP (L). The transfected cells 
could not be killed by TRAIL (data not shown). The sensitivity of GC-2 cells to TRAIL 
in the presence of cycoloheximide and in a p53-dependent manner cannot be explained 
by the suppression of c-FLIP (L) expression. Further work needs to be done to identify 
the factors responsible for this phenomenon, which could include abrogated NFκB or 
ERK signaling since these cell survival inducing pathways can be activated when some 
cell types are exposed to TRAIL (Secchiero et al. 2003).  
 
 In our in vivo studies, we observed an increase in c-FLIP (L) protein levels after 
MEHP exposure without any changes in the rates of its transcription and only in the p53 
knockout mice. Thus, activation of Fas appeared to be a requisite for the retention or 
stabilization of c-FLIP (L) in these germ cells, (Chandrasekaran and Richburg 2005).  
Similar to the in vivo data, we found that GC-2 cells maintained at the p53 non-
permissive temperature had increased levels of the c-FLIP (L) protein only after exposure 
to the JO2 antibody (Fig. 4.3 A). Upon examination of c-FLIP (L) protein expression in 
GC-2 cells treated with JO2, we detected ~3 fold increases in c-FLIP (L) after 3 and 6 h 
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of JO2 exposure (Fig. 4.3 A) only in cells lacking active p53. On the other hand, in cells 
at the permissive p53 temperature, c-FLIP (L) protein levels were decreased by nearly 
25-50 % of the control values after JO2 treatment (Fig. 4.3 A). The observed increase of 
c-FLIP in cells maintained at 37 ºC cells could not be accounted for by changes in its 
transcription as demonstrated by real-time PCR analysis (Fig. 4.3 B, i, ii). Taken together 
these observations suggest that in vitro, increases in c-FLIP levels in the absence of p53 
are due to an alteration in the stability and/or degradation of the protein as well.  
 
p53 influences c-FLIP ubiquitinylation in colon cancer cells (Fukazawa et al. 
2001). To examine if c-FLIP (L) was being degraded post-transcriptionally in a p53-
dependent manner we performed IP experiments to detect ubiquitinylation of c-FLIP (L) 
in GC-2 cells after JO2 exposure. In cells at the p53 non-permissive temperature, 
ubiquitin bound protein complexes pulled down by the anti-FLIP antibody and identified 
by a ubiquitin antibody could only be detected after JO2 treatment (Fig. 4.5 A, lanes 1-3), 
indicating that c-FLIP was being tagged for degradation in these cells only after Fas 
activation. Interestingly, in p53 permissive cells, very high expression levels of 
ubiquitinylated complexes could be detected in untreated control cells; with further 
increases in ubiquitinylation occuring 3 h after JO2 exposure (Fig. 4.5 A, lanes 4-6). A 
comparison of the levels of these polyubiquitin complexes revealed that the c-FLIP 
protein in the cells at the p53 permissive temperature were more robustly ubiquitinylated 
than those at the non-permissive temperature. The c-FLIP protein was therefore being 
more actively targeted to the proteasome for degradation in cells maintained at the p53 
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permissive 32 ºC. However, when the immunoprecipitated complexes were probed with 
an antibody against c-FLIP, the intensity of the bands of c-FLIP (L) protein complexed to 
ubiquitin from both cell types appeared similar (Fig. 4.5 B). The apparent similarity in c-
FLIP (+/- ubiquitin) levels between the samples can be accounted for by the differences 
in cell density of GC-2 cells grown at the two temperatures (more dense at 37 ºC) and 
hence the relative number of c-FLIP molecules pulled down during the IP assay. 
Experiments were also performed with the proteasome inhibitor MG-132 to demonstrate 
that inhibiting c-FLIP protein degradation would decrease the sensitivity of GC-2 cells at 
the p53 permissive temperature to JO2 (data not shown). However, the use of MG-132 
and another proteasome inhibitor lactacystin proved to be extremely cytotoxic to the GC-
2 cells even at concentrations less than 1 µM. 
 
 To test if the retention of c-FLIP (L) was responsible for the insensitivity of GC-2 
cells maintained at 37 ºC to JO2, we transiently reduced c-FLIP protein expression by 
transfecting these cells with siRNA against c-FLIP. siRNA transfected cells displayed a 
60-80 % reduction in the protein levels of c-FLIP (L) (Fig. 4.4 B) and this resulted in 
sensitizing the cells to JO2 induced Fas-activation. A near 4-fold increase in GC-2 
apoptosis was observed as a result of the siRNA c-FLIP protein reduction (Fig. 4.4 C). 
These results affirm a role for c-FLIP (L) in attenuating Fas activated apoptosis in germ 
cells. The increases in apoptotic levels from 1-2 % in control c-FLIP siRNA transfected 
cells to about 8 % in siRNA transfected cells exposed to JO2 are minimal though 
significantly different. These results can perhaps be explained by the measured low Fas 
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membrane expression levels (Fig. 4.1 B) in cells grown at the non-permissive p53 
temperature. Therefore, the combination of reduced membrane Fas levels and increased 
c-FLIP (L) expression in GC-2 cells after JO2 exposure likely account for the decreased 
sensitivity of these cells to apoptosis.  
 
An important insight gained by these experiments is the indication that the p53 
status of the cell may have a strong influence over the extent of c-FLIP (L) protein 
degradation within distinct germ cell subtypes. However, it should be noted that the 
ubiquitinylation of c-FLIP (L), as evident from the results in Fig. 4.5 B, occurred in both 
the cell types irrespective of their p53 status and only when Fas was activated (i.e. after 
JO2 treatment). Thus, the degradation of c-FLIP (L) is coupled to its recruitment to the 
DISC. We also show that the p53 status of GC-2 cells directly corresponds to the 
expression levels of Fas on the germ cell membrane. The binding of FasL to Fas on the 
membrane of germ cells determines the amount of DISC formed and therefore, DISC 
formation is likely more robust in p53 permissive GC-2 cells with the greater 
concentrations of Fas. The protein c-FLIP (L) is typically recruited to the formed DISC 
complex. To negate c-FLIP’s inhibitory influence and ensure that the cell undergoes 
apoptosis, the cell may mediate degradation of c-FLIP at this point of its recruitment. In 
our in vivo model, the expression levels of membrane Fas in the p53 -/- versus p53+/+ 
mice were not significantly different except at the 12 h time point after MEHP exposure. 
Thus in vivo the increased expression of c-FLIP (L) protein in the p53-/- mice between 1-
12 h after MEHP exposure correlated to an absence of their degradation as influenced by 
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the p53 status of the cell and perhaps not due to relative differences in the ability of these 
cells to form a DISC complex. An analysis of DISC formation in germ cells of p53+/+ 
and p53 -/- mice exposed to MEHP would therefore be important to clarify whether p53 
status influences the relative amount of DISC formed, and hence c-FLIP (L) degradation. 
In GC-2 cells however, the p53 protein does influence the expression levels of membrane 
Fas and hence the extent of c-FLIP retention.  
 
In our in vivo model we weren’t entirely able to correlate the differences in 
apoptosis between p53+/+ and p53 -/- mice to p53 dependent alterations of membrane 
Fas levels, perhaps due to the use of total testicular lysates for analysis. Nevertheless we 
were able to demonstrate that p53 influenced the stability/retention of the c-FLIP (L) 
protein after MEHP exposure, which was confirmed by the ubiquitinylation studies 
carried out in GC-2 cells. Our results from both studies, when taken together, indicate 
that the activation of p53 in germ cells due to cellular stress leads to Fas activated 
apoptosis by ensuring the degradation of c-FLIP (L) protein.  
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Chapter 5: The influence of p53 status on the localization of Fas to lipid raft 
domains of germ cell plasma membranes: Correlation to increased 
sensitization of germ cells to MEHP-induced apoptosis 
 
5.1. Introduction and Rationale: 
 
 In Chapter 3, an in vivo animal model was used to demonstrate that p53 plays a 
role in the increased cell membrane localization of Fas and DR5 in germ cells after 
exposure to MEHP (Fig. 3.2 A,B). Our in vitro GC-2 cell model demonstrated that germ 
cells could only be sensitized to apoptotic cell death in the presence of anti-Fas antibodies 
and not with TRAIL treatment (Fig. 4.2 C-F).  Thus, in response to MEHP exposure 
germ cell apoptosis is most likely not mediated by a DR5-activated pathway. 
Interestingly, the induction of increased Fas expression at the germ cell membranes is a 
late event that only coincides with a second wave of germ cell apoptosis, while increased 
membrane DR5 was observed as early as an hour after MEHP exposure and maintained 
at high levels thereafter. MEHP induced toxicity yielded both an early and a late increase 
in germ cell apoptosis that peaked at 1.5 h and 24 h respectively post-exposure (Fig. 3.1 
E).  Both waves were preceded by increased processing and hence activation of caspase-8 
(Fig. 3.4 A-C).  These results indicate an activation of death receptors during both the 
early and late apoptotic events. However, in the absence of increased membrane Fas 
expression for the first 6 h after MEHP exposure (Fig. 3.2 A, C), and perhaps a lack of 
contribution from the augmented DR5 membrane receptors toward germ cell apoptosis, 
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an alternate explanation is required to clarify how increases in caspase-8 processing occur 
coincident with the first wave of apoptosis.  
 
 The increases in c-FLIP (L) levels in the p53 -/- mice as early as 1 h after 
exposure to MEHP could indicate that c-FLIP degradation in the p53+/+ mice may 
sustain caspase-8 activation with only the basal levels of the Fas receptor being present 
(Fig. 3.5 B,C).  However, as shown in Fig. 3.5 A, the levels of c-FLIP (L) in the p53+/+ 
mice are not significantly decreased after MEHP treatment and may not completely 
account for the enhanced caspase-8 activation. Therefore, we hypothesize that in the 
absence of their increased expression, Fas receptors are targeted to a specific 
microdomain within the cell membrane called lipid rafts in a p53-dependent manner, 
enabling the formation of the DISC and hence the processing of caspase-8 in response to 
MEHP. Lipid rafts are specialized microdomains in cell membranes that are cholesterol 
and sphingomyelin enriched (for review see Zajchowski and Robbins 2002). A large 
number of signaling molecules that mediate different signaling pathways such as 
epidermal growth factor receptor, ceramide, diacylglycerol, Ras, Shc, Src-family of 
kinases and many more can be found localized in lipid rafts. In fact, the DISC is formed 
in the lipid rafts of CD4+ T cells in the event of Fas-induced apoptosis (Scheel-Toellner 
et al. 2002). The movement of Fas receptors within the membrane to mediate signaling 
could explain enhanced processing of caspase-8 in the absence of changes to Fas 
membrane levels after toxicant exposure. 
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 Lipid rafts are detergent resistant microdomains that are typically associated with 
integral membrane proteins called caveolins and flotillins and form a liquid ordered phase 
in membranes due to their lipid composition (Brown and London 1997; Zajchowski and 
Robbins 2002). These domains not only contain cholesterol and sphingomyelin, but also 
glycosphingolipids and proteins anchored to the plasma membrane by 
glycophosphotidylinositol. The ordering of the domains by the presence of a high 
concentration of saturated fatty acid chains with intercalated cholesterol causes the 
resistance of these domains to detergents. Lipid rafts can be separated thus based on both 
a detergent insolubility and low buoyant density in sucrose density gradients. Caveolins 
are the principal protein component of lipid rafts and may be found associated with 
flotillins in many cell types. Flotillin-2 or epidermal surface antigen (ESA) is more 
ubiquitously expressed than Flotillin-1 and is expressed in the testis (Volonte et al. 1999).  
 
 Antitumor agents such as the ether lipid, 1-O-octadecyl-2-O-methyl-rac-glycero-
3-phosphocholine, cisplatin and the natural phytoalexin, resveratrol (3,5,4’-
trihydroxystilbene), cause the redistribution of Fas to membrane lipid rafts to initiate 
apoptosis of either leukemic or colon cancer cells (Gajate and Mollinedo 2001; Delmas et 
al. 2004; Lacour et al. 2004). Muppidi and Siegel (Muppidi and Siegel 2004) 
demonstrated that restimulation of activated T cells lead to their death due to the 
translocation of Fas to lipid raft domains. The same authors also demonstrated that type I 
and type II cells differ in their ability to respond to Fas activation due to the differences 
in Fas localization at lipid rafts. These different studies demonstrated that the disruption 
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of lipid rafts by cholesterol depleting agents such as methyl β-cyclodextrin (MBCD) or 
filipin, also disrupted the localization of Fas to lipid rafts and significantly reduced Fas-
mediated apoptosis. Hence, based on the above studies that demonstrate that relocation of 
Fas within the cell membrane can sensitize cells to Fas-mediated cell death, we decided 
to test for differences in membrane Fas localization in germ cells from p53 -/- and p53 




5.2.1. Expression Profile of Fas in Lipid Raft Fractions of GC-2 Cell Membranes: 
 
 GC-2 cells maintained at both the p53 permissive and non-permissive 
temperatures were subjected to sucrose density gradient ultracentrifugation to separate 
lipid raft domains in their cell membranes from the non-lipid raft domains. As shown in 
Fig. 5.1, the fractions obtained by ultracentrifugation were analyzed for both Fas and 
Flotillin-2 expression by western blot analysis. As expected, Flotillin-2 expression was 
abundant in the fractions obtained from the top layers of the sucrose density gradient, i.e. 
the fractions representing the least dense and detergent resistant layers of the gradient 
(Fractions 3 and 4 in this case, Fig. 5.1 A,B). Therefore, these fractions deemed the lipid 
raft fractions were analyzed further for Fas expression. Cells at the p53 permissive 
temperature had abundant expression of Fas in almost all fractions unlike cells at the non-
permissive temperature (Fig. 5.1 A,B). Fas levels in lipid raft fractions 3 and 4 were only 
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Fig. 5.1. Expression profile of Fas in lipid raft fractions of GC-2 cells. Representative 
blots (from 2 sample sets) for Fas and Flotillin-2 expression in cell membrane fractions of 
GC-2 cells at 37 ºC (A) and 32 ºC (B), obtained by sucrose density gradient 
ultracentrifugation. Fractions 3 and 4 represent lipid raft fractions, while fractions 8-10 
donate non-lipid raft fractions. 
Fas 
Fas 
A.                                                37 ºC 
B.                                                32 ºC 





slightly higher in cells at the p53 permissive temperature than those at the non-permissive 
temperature when normalized to corresponding Flotillin-2 levels in each fraction (data 
not shown).  
 
5.2.2. Disruption of Lipid Rafts in GC-2 Cells at the p53 Permissive Temperature Does 
Not Significantly Reduce Sensitivity of these Cells to JO2: 
 
 GC-2 cells maintained at 32 ºC were pretreated with 1 mM, 5 mM or 10 mM of 
the cholesterol depletor MBCD for 30 min in serum free media at 37 ºC, washed and 
exposed to JO2. MBCD caused a collapse of cell membrane microdomains as evident 
from the clustering of Flotillin-2 protein in the non-raft fractions (Fractions 8-10) only (0 
h sample, Fig. 5.2 A) compared to untreated cells as determined by western blot analysis. 
Importantly, 6 h after the MBCD had been washed out, GC-2 cells still displayed the 
collapsed membrane architecture with Flotillin-2 remaining concentrated in the non-raft 
fractions (Fig. 5.2 B). The higher doses of MBCD (5 and 10 mM) were protective against 
JO2 mediated apoptosis at the early time points of 3 and 6 h after exposure as 
demonstrated by flow cytometric analysis of annexin-V positive cells, but not at the later 
time point of 12 h (Fig 5.2 C). However, this protection was significant only at the 3 h 
time point, wherein cells exposed to JO2 after pretreatment with MBCD experienced a 
nearly 40-50 % reduction in overall levels of apoptosis. 
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Fig. 5.2. Analysis of sensitivity of GC-2 cells at the p53 permissive temperature to 
JO2 after disruption of lipid raft domains. (A) and (B) are representative blots for 
Flotillin-2 (~46 kDa) in control or MBCD treated GC-2 cells at the p53 permissive 
temperature. (A) represents samples from cells collected 0h after MBCD pre-treatment, 
while (B) represents samples from cells collected 6h after the pre-treatment. (C) A 
graphical representation of annexin-positive GC-2 cells, pre-treated with MBCD and 
exposed to JO2, as well as matched time and pre-treatment only controls. The results 
represent data from 2 independent experiments. 
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Control 
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 5.2.3. Absence of  Fas Expression Changes in Lipid Raft Domains of Testicular Germ 
Cells after MEHP Exposure Regardless of p53 Status: 
 
 Testicular samples from p53+/+ and p53 -/- mice were also subjected to sucrose 
density gradient ultracentrifugation to separate lipid raft membrane fractions. For 
testicular samples, Flotillin-2 expression was most significant in fraction 5 (Fig 5.3 A) 
and all further analyses of Fas expression were carried out in the fraction 5 samples for 
each MEHP treated sample. Western blot analyses of Fas expression in testicular samples 
showed no significant changes to Fas expression (or Flotillin-2) after exposure to MEHP, 
in lipid raft fraction 5 (Fig 5.3 C). Moreover, the ability to detect Fas expression in these 




Sensitivity to MEHP in the testis is manifested in the form of increased germ cell 
apoptosis. We hypothesized that p53 plays an important role in sensitizing specific germ 
cells subtypes to apoptosis caused by withdrawal of support from MEHP injured Sertoli 
cells, via their increased expression of membrane Fas. However, despite some evidence 
of increased membrane localization of Fas in our in vivo model (Chapter 3), we were 
unable to completely correlate the activation of the Fas pathway (i.e. increased processing 
of procaspase-8) to increased expression of Fas on germ cell membranes in response to 





Fig 5.3. Analysis of changes in Fas localization to lipid raft domains. (A) is a 
representative blot for Flotillin-2 expression in testicular membrane fractions obtained by 
sucrose density ultracentrifugation. (B) Representative blots for Fas expression in lipid 
raft fraction 5 from testes of p53+/+ and p53 -/- mice in response to MEHP exposure. 












     0h           1h           1.5h         3h            6h          12h 
p53 -/- 





movement to the germ cell membrane, its movement within the cell membrane into a 
specific functional microdomain could account for activation of the Fas pathway after 
MEHP mediated injury. The relocation of Fas into lipid raft domains within the cell 
membrane is responsible for the sensitization of a number of cell types including T cells, 
colon cancer cells, and malignant mesothelial cells to apoptosis (Gajate and Mollinedo 
2001; Delmas et al. 2004; Lacour et al. 2004; Muppidi and Siegel 2004). Hence, we 
evaluated if testicular samples from p53+/+ and p53 -/- mice exposed to MEHP and GC-
2 cells maintained at both the p53 permissive and non-permissive temperature, were 
capable of modifying Fas levels in their membrane lipid raft domains in response to 
cellular stress and in a p53-dependent manner to mediate apoptosis. 
 
 GC-2 cells were analyzed for differences in lipid raft expression of Fas receptors 
at both 37 ºC and at 32 ºC. Although the cells at the p53 permissive temperature 
expressed extremely abundant levels of Fas protein in almost all the fractions obtained 
from the sucrose density gradient fractionation procedure, the levels of Fas in the 
fractions corresponding to the lipid raft domains (Fractions 3 and 4) were only modestly 
higher than in fractions from the 37 ºC cells (when normalized to Flotillin-2 levels, Fig. 
5.1 A,B). GC-2 cells at 37 ºC had increased retention of c-FLIP (L) compared to cells at 
32 ºC as discussed in Chapter 4, and could be sensitized to anti-Fas induced apoptosis 
when c-FLIP levels were knocked down. Thus it appears that GC-2 cells are capable of 
mediating Fas localization in lipid rafts irrespective of their p53 status and that raft 
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localization may not be the primary factor responsible for different sensitivities of these 
cells to anti-Fas treatment.  
 
 Cholesterol depletion from cell membranes disrupts lipid raft domains as they are 
cholesterol enriched domains. Thus, all proteins located within lipid raft domains would 
cluster in non-raft domains when these rafts are disrupted or dismantled. If Fas is 
localized in lipid rafts, a cholesterol depletor such as MBCD should cause its relocation 
as well as that of Flotillin-2, a raft associated protein from that domain. GC-2 cells at the 
p53 permissive temperature were exposed to MBCD pretreatment. As expected, this 
pretreatment caused Flotillin-2 relocation from raft domains in the cell membranes of 
GC-2 cells (Fig 5.2 A,B). However, despite the disruption of lipid rafts, the GC-2 cells 
were not completely protected against JO2 treatment, with significant protection being 
achieved only for a brief period of time (up to 3 h) after exposure to JO2 (Fig 5.2 C). 
This lack of protection against JO2 could not be explained by any inherent cytotoxic 
effects of MBCD. The appropriate sample control cells exposed to MBCD but not JO2, 
displayed slightly higher levels of apoptosis compared to untreated controls, but these 
levels were not significantly higher. Interestingly, a recent report (Gniadecki 2004) 
showed that cholesterol depletion leading to Fas clustering in non-raft domains in the 
plasma membranes of keratinocytes improved the ability of these cells to undergo Fas-
induced apoptosis. Again, activation of Fas mediated apoptosis in GC-2 cells may not 
depend on the localization of Fas to lipid raft microdomains.  
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 Testicular samples from p53+/+ and p53 -/- mice exposed to MEHP were also 
analyzed for changes in Fas expression in lipid raft domains by western blots. When Fas 
expression in a specific fraction 5, enriched in Flotillin-2 was examined, no significant 
changes could be observed in response to MEHP exposure (Fig. 5.3 B). No movement of 
Fas into these lipid raft domains above control expression levels could be observed. Thus, 
we were unable to determine if MEHP induced-Sertoli cell injury which mediates the 
paracrine activation of Fas on germ cells requires their localization to lipid raft domains. 
We cannot rule out the possibility that our analysis was not very sensitive as we had a 
difficult time in visualizing the bands for Fas protein. On the other hand, a recent report 
(Henkler et al. 2005) demonstrated that membrane associated FasL molecules could 
induce the clustering of Fas receptors without needing Fas to localize at lipid rafts.  
Perhaps, the increases in Sertoli cell FasL expression observed in response to MEHP 
(Richburg et al. 1999) is sufficient to trigger Fas activation corresponding to the first 
wave of germ cell apoptosis in the p53+/+ mice without requiring movement of 
additional receptors to the germ cell membrane. Furthermore, a more cell specific 
analysis of membrane Fas levels in the MEHP-sensitive spermatocytes and spermatids, 
could resolve some of these questions. The in vivo data looked at the membrane levels of 
Fas receptor from a whole testis preparation. Thus, contributions from other cell types 
within the testis would have obscured changes in Fas expression, specific to the cell types 
most sensitive to the MEHP toxicity. Taken together, we could not determine whether 
Fas activation in germ cells in response to MEHP induced Sertoli cell injury, requires the 
localization of Fas to lipid rafts in a p53-dependent manner. 
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Chapter 6:  Concluding Remarks 
 
DEHP is a commonly used plasticizer found widely dispersed in the natural 
environment due to its constant leaching out from plastic products.  The study of the 
effects of DEHP and its active toxic metabolite MEHP on the reproductive system arise 
from the observation of testicular atrophy in rodents and other higher mammals exposed 
to DEHP or MEHP. Testicular atrophy is preceded by increases in germ cell apoptosis 
caused by the injury to Sertoli cells by MEHP, thereby compromising their ability to 
function properly.  Various studies have been carried out to understand the mechanism by 
which both Sertoli cells and germ cells initiate cellular changes leading to enhanced germ 
cell apoptosis after exposure to MEHP. The Fas-FasL signaling pathway plays a major 
role in initiating germ cell death after MEHP mediated Sertoli cell injury. Injured Sertoli 
cells were found to have an increased expression of FasL in response to MEHP, thereby 
triggering apoptosis of Fas expressing germ cells, specifically spermatocytes and round 
spermatids. However, the factors responsible for sensitizing germ cells to Fas mediated 
cell death, were undetermined at the time of commencement of the work presented in this 
dissertation. We hypothesized that the tumor suppressor p53 may play a role in 
mobilizing Fas receptors to the cell membranes of germ cells and hence sensitize them to 
FasL mediated cell death in response to MEHP.  
 
Our in vivo results utilizing p53+/+ and p53 -/- mice demonstrated that p53 likely 
played a transcription-independent role in increasing germ cell Fas membrane levels after 
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MEHP exposure, similar to the demonstration by Bennett et al. (Bennett et al. 1998) of 
Fas receptor trafficking upon activation of p53. However, the p53 dependent increases in 
Fas membrane levels preceded a second apoptotic peak in response to MEHP in the 
p53+/+ mice, and not the first early peak. Interestingly, this biphasic apoptotic response 
seemed to be initiated by the activation of caspase-8, a proximal mediator of the death 
receptor activated pathways in cells. Hence, in the absence of the predicted Fas 
membrane increases corresponding to the early peak of apoptosis, we looked for alternate 
explanations for the apparent activation of the Fas pathway in the p53+/+ mice.  
 
We established that protein levels of c-FLIP (L), an inhibitor of caspase-8 
activation and hence the Fas pathway, were enhanced only in the p53 -/- mice as early as 
an hour after exposure to MEHP, without any apparent differences in their transcription 
compared to levels in p53+/+ mice. Additionally, recent reports have implicated that the 
relocation of existing Fas receptors into special membrane microdomains called lipid 
rafts, is adequate for the activation of the Fas pathway in the absence of increased cell 
membrane localization of these receptors. We were unable to establish such a relocation 
of Fas into lipid raft domains to explain the sensitivity of p53+/+ mice to MEHP 
corresponding to the early apoptotic peak at 1.5 h after exposure.  These results therefore 
implicate a role for p53 in the activation of Fas mediated germ cell apoptosis mediated 
perhaps by p53-dependent degradation of c-FLIP (L), and also perhaps the increased 
membrane expression of Fas leading to the second peak of apoptosis, but not Fas 
activation via lipid raft localization.   
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We used an in vitro GC-2 germ cell line model, comprising transformed cells with 
a temperature sensitive p53 mutation, to clarify some of the questions raised by our in 
vivo studies.  By changing the temperature at which these cells were maintained, we 
created cell systems with active or inactive p53.  These GC-2 cells were of spermatocytic 
origin and of the cell type most sensitive to MEHP toxicity in vivo. As expected, they 
were resistant to the direct addition of MEHP. Instead to mimic FasL on injured Sertoli 
cells that activate germ cell Fas receptors, we utilized the anti-Fas antibody JO2 to 
prompt the cell death of GC-2 cells. We demonstrated that the activation of p53 in these 
cells caused an increased membrane localization of Fas receptors and hence their 
increased sensitivity to cell death in response to JO2. The apparent inability of JO2 to kill 
GC-2 cells at the p53 non-permissive temperature was correlated to the reduced 
degradation of c-FLIP (L), as a knockdown of the c-FLIP (L) protein could sensitize 
these cells to JO2. In the cells at the p53 permissive temperature on the other hand robust 
ubiquitinylation and hence degradation of the c-FLIP (L) protein occurred after Fas 
activation. These studies with GC-2 cells confirmed that the activation of the Fas 
pathway in germ cells, triggered the degradation of c-FLIP (L). However, the direct role 
of p53 in mediating this degradation could not be established. Instead, p53 was shown to 
affect the membrane expression levels of Fas, which in turn were found to affect the 
amount of c-FLIP (L) protein being retained in the cells.  
 
When the results from the in vivo and in vitro studies are taken together, they 
establish that the activation of the Fas pathway in germ cells is regulated by the 
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modification of the protein levels of c-FLIP (L). The reduction in overall levels of germ 
cell apoptosis in response to MEHP in the p53 -/- mice indicates the involvement of p53 
as a stress sensor in germ cell apoptosis. The precise role played by p53 in this model is, 
however not very clear. The results from the in vivo studies do not reflect a strong role for 
p53 in the alteration of membrane expression levels of Fas, which was postulated to be 
the key to germ cell sensitivity to increased FasL expression on Sertoli cells in response 
to MEHP mediated injury. On the other hand, a 10-fold increase in membrane expression 
of Fas in GC-2 cells is based on the activation of p53, which distinguishes the sensitivity 
of the p53 permissive and non-permissive cells to JO2 mediated apoptosis.  
 
The Fas membrane expression results from the in vivo studies are based on the 
analysis of membrane levels of Fas in total testicular lysates. The contribution from 
several different cell types to the analysis may have obscured any significant changes 
experienced by specific germ cell subtypes such as spermatocytes and round spermatids 
that are specifically sensitive to the MEHP effects. Furthermore, caspase-8 activation that 
precedes the two apoptotic peaks in our model is p53-dependent; this implies that death 
receptor activation in response to MEHP is also p53-dependent. Perhaps by analyzing the 
membrane expression levels of Fas in enriched germ cell populations, we may resolve the 
apparent discrepancy in caspase-8 activation and lack of Fas localization to the 
membrane in p53+/+ mice. Additionally, no analyses of membrane FasL expression were 
carried out in the p53+/+ and p53 -/- mice. Biphasic changes in FasL expression in 
response to Sertoli cell injury could account for the activation of caspase-8 in the manner 
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described in our results. Thus the role of p53 in the membrane localization of both Fas 
and FasL remains to be clarified. 
 
The degradation of c-FLIP (L) protein upon activation of the Fas receptors in 
germ cells was established from experiments using GC-2 cells. However, the 
involvement of p53 in mediating this degradation directly could not be proven. The 
absence of any significant differences in membrane Fas levels between testicular cells of 
p53+/+ and p53 -/- mice, led us to initially believe that the retention of the c-FLIP (L) 
protein in response to MEHP in the p53 -/- mice indicated a role for p53 in the 
degradation of c-FLIP.  p53 transcribes E3 ligases including Mdm2 and PirH2 (Leng et al. 
2003; Michael and Oren 2003). E3 ligases are proteins that attach ubiquitins to specific 
proteins targeting them for degradation by the proteasome. It was therefore speculated 
that p53 could potentially aid in the transcription of the E3 ligase specific for c-FLIP (L). 
The in vitro results however implicate the amount of membrane Fas expression to be the 
factor limiting c-FLIP (L) degradation; GC-2 cells at the non-permissive p53 temperature 
express much less Fas at the cell membrane and may not recruit enough c-FLIP 
molecules to the DISC to ensure their degradation. To resolve the role of p53 status on c-
FLIP ubiquitinylation and degradation, future studies should involve the utilization of 
two cell lines with comparable membrane Fas expression. This will enable us to rule out 
the contribution from Fas related effects.  
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Another potential line of research would be to identify the E3 ligase specific for 
the c-FLIP (L) protein. Although several researchers have identified c-FLIP as a potential 
target for degradation/removal in cancer cells, in order to sensitize them to death from 
TRAIL or anti-Fas treatment (Baumler et al. 2003; Rippo et al. 2004; Zhang et al. 2004; 
Watanabe et al. 2005), no research has been done to determine how c-FLIP is degraded 
physiologically to mediate death receptor activation. Our data suggests that c-FLIP is 
actively degraded when it is recruited to the DISC, i.e. after Fas activation. Determining 
how this degradation is brought about would be an interesting question to answer. 
Recently, it was shown that certain adaptor proteins that are involved in mediating TNFR 
and other death receptor signaling, called TNF-R-associated factors (TRAFs), especially 
TRAF2 and TRAF6 are E3 ubiquitin ligases (Shi and Kehrl 2003; Sun et al. 2004). Other 
reports have indicated that the activation of Fas in Jurkat T cells and Raji B cells, leading 
to the formation of DISC and recruitment of c-FLIP (L), promotes NFκB and ERK 
signaling through the recruitment of TRAF1 and 2, and RIP and Raf-1 to c-FLIP 
(Kataoka et al. 2000). Additionally, when c-FLIP (L) is processed by caspase-8 at the 
DISC, the N-terminal fragment of c-FLIP (p43) more readily interacts with TRAF2 to 
mediate NFκB signaling (Kataoka and Tschopp 2004).  Thus, the potential exists for 
TRAF2 to be the specific E3 ligase for c-FLIP, as TRAF6 does not bind to c-FLIP. 
  
Having identified what may be the potential mechanism by which MEHP toxicity 
ensures cell death of primary spermatocytes and round spermatids, future studies also 
should be aimed at addressing the reason for the sensitivity of these specific cell types.  
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The answer may be related to the cell-type specific expression of c-FLIP (L) and its 
modification in response to Fas activation. The continuous expression of the p53 protein 
in spermatocytes and perhaps its ability to influence both the membrane levels of Fas and 
the stability of c-FLIP may be the key to this mechanism, as the half life of p53 in most 
other cells is typically only 30 min (Schwartz et al. 1993). Spermatocytes may be more 
sensitive to the paracrine activation of Fas by Sertoli cell FasL, due to the ability of the 
constitutively expressed p53 in the spermatocytes to be activated after the withdrawal of 
physical or hormonal support by Sertoli cells after toxicant-induced injury. To summarize 
our results, a schematic is provided in Fig. 6.1 as a representation of our current model 
predicting the mechanism by which the Fas pathway may initiate testicular germ cell 
apoptosis in response to MEHP. 
 
Even after several decades of research the exact mechanism by which MEHP 
mediates Sertoli cell injury remains elusive. Several recent studies have only added to the 
confusion with the suggestion of several additional mechanisms by which MEHP may 
affect Sertoli cell functions. For instance, in addition to the physical changes such as 
formation of vacuoles, and collapse of microtubule and vimentin filaments in Sertoli cells, 
recent data suggest that molecules such as flamingo 1 involved in cell adhesion between 
germ cells and Sertoli cells are also affected by exposure to MEHP (Richburg et al. 2002). 
Additionally, exposure to DEHP was found to cause a decrease in testicular levels of 
antioxidants such as free thiols, GSH and ascorbic acid, and also led to the generation of 
reactive oxygen species (ROS) in the testis (Kasahara et al. 2002). 
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Fig. 6.1. Representation of the proposed model for Fas mediated germ cell apoptosis 
after testicular exposure to MEHP. Our results from both our in vivo and in vitro 
studies when taken together, indicate that p53 in germ cells in response to MEHP-
induced Sertoli cell injury, promotes Fas activated germ cell apoptosis by instigating the 
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The generation of ROS in Sertoli cells could potentially activate the stress 
activated kinase JNK or c-Jun N terminal kinase (Chen et al. 2001). Active JNK 
phosphorylates the c-Jun protein which is typically a component of the activator protein-1 
or AP-1 transcription factor. This transcription factor is one of the transcriptional 
regulators of FasL expression (Kavurma and Khachigian 2003). Thus, ROS generation in 
the testis in response to exposure to MEHP may activate JNK and cause the increased 
transcription of FasL, which is an observed phenomenon in this toxicity model. 
Additionally, due to the effects of MEHP in causing peroxisomal proliferation in the liver, 
it has also been investigated for its ability to stimulate the activation of peroxisome 
proliferator-activated receptors or PPAR’s in the testis. MEHP increased the nuclear 
localization of PPAR α and γ receptors and prevented the localization of the retinoic acid 
receptor α (RARα) also to the nuclei of Sertoli cells (Bhattacharya et al. 2005). The 
relevance of these changes has yet to be elucidated. MEHP induced PPAR activation 
leads to the suppression of aromatase transcription in granulosa cells of the ovary, and 
hence reduced estradiol production (Lovekamp-Swan and Davis 2003). On the other hand, 
RARα deficient mice develop testicular degeneration and sterility and the absence of 
nuclear localization of this protein prevents its activation (Lufkin et al. 1993). The 
activation or non-activation of the three nuclear receptors adds to the growing list of 
potential ways by which MEHP affects Sertoli cells, which only makes it harder to 
determine the exact mechanism of action of this toxicant.  
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 Ultimately the ability of MEHP to affect a number of Sertoli cell functions, 
perhaps by a single mechanism or by several different ones, is responsible for the 
disruption of the microenvironment in the adluminal compartment of seminiferous 
tubules. Human exposure to phthalates from the environment may not cause testicular 
toxicity on the scale demonstrated by the rodent studies. However, the utility of these 
studies lies in the appreciation of the importance of Sertoli cells as support cells, and 
hence their contribution toward the proper functioning of spermatogenesis which 
eventually affects the fertility of the organism. The ability of germ cells to respond to the 
diminished capacity of Sertoli cells remains a very critical homeostatic mechanism within 
the testis. One must remember that not all chemical or physical agents that the male 
human populace is exposed to will cause disruption of Sertoli cell functions. Nevertheless, 
the identification of the cellular and molecular factors that affect germ cell death in 
response to Sertoli cell injuries are equally important to the understanding of how various 
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